PASKIN: target protein identification and kinase activity regulation by phospholipids by Tröger, Juliane Steffi
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2007
PASKIN: target protein identification and kinase activity regulation by
phospholipids
Tröger, Juliane Steffi
Abstract: Zusammenfassung Kürzlich haben wir ein neue Serin/Threonin Kinase in Säugetieren iden-
tifiziert, die wir PASKIN genannt haben. In der Hefe wurde gezeigt, dass PASKIN unter Stress die
Speicherung von Glykogen reduziert sowie die Proteintranslation vermindert. In Säugetierzellen phos-
phoryliert PASKIN die Glykogen-Synthase und scheint glucoseabhänig an der Insulinproduktion von
￿-Zellen im Pankreas beteiligt zu sein. PASKIN ist am stärksten in der postmeiotischen Phase der Sper-
matogenese exprimiert. Von uns durch homologe Rekombination erzeugte PASKIN knock-out Mäuse
weisen eine normale Entwicklung, Wachstum, Fortpflanzung sowie keine Beeinträchtigung der Frucht-
barkeit auf. Um die Funktion von Paskin zu untersuchen, wurde ein Zwei-Hybrid Screening mit einer
HeLa cDNA Bibiliothek in der Hefe durchgeführt, um mögliche Interaktionspartner von PASKIN zu
identifizieren. Ein identifiziertes Target von PASKIN ist der eukaryotische Translations- Elongationsfak-
tor eEF1A1, welcher mit PASKIN in vitro und in vivo interagiert. Die Phosphorylierung von eEF1A1
durch PASKIN an Threonin 432 könnte auf eine Aktivierung von eEF1A1 hinweisen, die dann zu einer
erhöhten translationellen Elongation führt. Zum ersten Mal konnten wir zudem zeigen, dass PASKIN
durch Phospholipide aktiviert wird, welches sich auf eine mögliche Aktivierung oder Inhibierung der In-
teraktionspartner von PASKIN auswirken könnte. Die Identifizierung von Interaktionspartnern wird in
Zukunft dabei helfen, die Funktion von PASKIN besser zu verstehen. Abstract The development of a
functional nervous system is a highly complex process. Four main conserved protein families have been
identified that serve as guidance cues for migrating neurons and axonal growth cones: netrins, Slits,
semaphorins and ephrins. Nevertheless, it is still unclear how a restricted set of guidance molecules
is able to give rise to highly differentiated guidance choices of individual axons. Heparan sulfate pro-
teoglycans (HSPGs) are part of the extracellular matrix through which axons navigate. HSPGs carry
differentially modified sugar side chains, which have been proposed to convey information to the nervous
system. However, it was not known which HSPGs are implicated in neural development and how they
function to control neural patterning. In this dissertation, I describe that the cell surface HSPG syndecan
SDN-1 acts cell-autonomously in neurons to regulate neuronal migration and axon guidance (chapter 2).
Double mutant analyses place SDN-1 in the Slit/Robo signaling pathway, but provide also evidence for
a parallel axon guidance pathway that is controlled by at least one additional HSPG, which is likely
to be the main target of the HS C5-epimerase HSE-5 (chapter 2). In order to identify HSPGs in the
SDN-1-independent pathway, I first examined available HSPG mutants for neural defects and performed
RNAi against known HSPGs (chapter 3). To identify new components in both HS-dependent signaling
pathways, I developed an enhancer screen strategy that yielded 14 enhancer mutations (chapter 4). The
isolated enhancer mutations are likely to reveal new genes involved in SDN-1-regulated axon guidance
signaling. In a second project, I have studied the functional conservation of UNC-69, a C. elegans axon
guidance protein. I could show that the chicken homolog of UNC-69 is highly expressed in the developing
nervous system of the chicken embryo and that its inactivation by RNAi leads to axon guidance defects
(chapter 5). This shows that the nematode C. elegans is a powerful model system to identify new regu-
lators of axon guidance signaling and promises to lead to a better understanding of the mechanisms that
control nervous system development.
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1. Abbreviations 
1. ABBREVIATIONS 
 
Aer   aerotaxis sensor receptor 
AhR   aryl hydrocarbon receptor 
AMPK  AMP-activated kinase 
ArcB   aerobic respiration control sensor protein 
ARNT   aryl hydrocarbon receptor nuclear translocator 
BMAL  brain and muscle ARNT-like protein 
CAF20  Cap-associated factor 20 
CCAMK  calcium/calmodulin-dependent protein kinase  
CLOCK  circadian locomoter output cycles kaput protein 
DAG   diacylglycerol 
DOG   dioctanoylglycerol 
DNA-PKCS  DNA-dependent protein kinase catalytic subunit 
eEF   eukaryotic translation elongation factor 
eIF   eukaryotic translation initiation factor 
EGF   epidermal growth factor  
Fos Finkel-Biskis-Jinkins (FBJ) murine osteosarcoma virus oncogene, 
transcription factor 
GLUT   glucose transporter  
Gsy2   glycogen synthase 2 
GDP   guanosine diphosphate 
GST   glutathione-S-transferase 
GTP   guanosine trisphosphate 
H2AX   H2A histone family, member X 
HERG  human eag-related gene 
HIF   hypoxia-inducible factor 
Hsp70   heat-shock protein 70 
IP3   inositol trisphosphate 
MBP   maltose-binding protein 
MIN6   mouse insulinoma cell line 
NifL   nitrogen fixation regulatory protein 
NPAS   neuronal PAS protein  
NMR   nuclear magnetic resonance 
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1. Abbreviations 
p53   53 kDa tumor suppressor protein 
p300   300 kDa protein, histone acetyl transferase 
PA   phosphatidic acid 
PAS   PER/ARNT/SIM 
PASKIN  PAS domain kinase 
PC   phosphatidylcholine 
PDX-1  pancreatic duodenal homeobox-1 transcription factor-1 
PE   phosphatidylethanolamine 
PER   Drosophila period clock protein 
PI   phosphatidylinositol 
PIP2   phosphatidylinositol bisphosphate 
PLC/D  phospholipase C/D 
PKC   protein kinase C 
PMA   phorbol 12-myristate 12-acetate 
PS   phosphatidylserine 
PYP   photoactive yellow protein 
Raf-1   root abundant factor, v-raf-1 murine leukemia viral oncogene homolog  
S   sphingomyelin 
SAP   SAF-A/B, Acinus and PIAS motif 
SIM   Drosophila single-minded protein  
Sds22   protein phosphatase, regulatory subunit 7 
Snf1   sucrose non-fermenting 1 protein kinase 
Sp1   stimulator protein 1, transcriptional factor 
Tif11   translation initiation factor 1A 
Ugp1   UDP-glucose pyrophosphorylase 
VEGF   vascular endothelial growth factor 
vWA   von Willebrand factor A domain 
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2. Zusammenfassung 
2. ZUSAMMENFASSUNG 
 
In der Zelle stellt die Phosphorylierung von Proteinen eine wichtige Form der 
posttranslationellen Modifikationen dar. Kürzlich haben wir eine neue Serin/Threonin Kinase 
in Säugetieren identifiziert, die wir PASKIN genannt haben. PASKIN besitzt zwei PAS 
Domänen mit hoher Ähnlichkeit zu dem bakteriellen Sauerstoffsensor FixL, der in 
verschiedenen Rhizobium Arten vorkommt. PAS Domänen agieren als Proteinsensoren, die 
fähig sind, externe Reize wie zum Beispiel Veränderungen der Lichtintensität, des 
Sauerstoffpartialdrucks, des Redoxpotentials, und elektrischen Spannung sowie die 
Konzentration verschiedener Liganden zu messen. Zusätzlich können PAS Proteine von 
Säugetieren als Kopplungsstelle für die Dimerisierung von Transkriptionsfaktoren dienen. 
Beispiele dafür findet man in der Antwort auf körperfremde Substanzen, in der Adaptierung 
auf Hypoxie und in der Tagesrhythmusregulierung. Neben den beiden PAS Domänen besitzt 
PASKIN als katalytische Domäne eine Serin/Threonin Kinasedomäne, die auf Sequenzebene 
den AMP Kinasen ähnelt. Es wird vermutet, dass PASKIN durch die Bindung eines Liganden 
aktiviert wird. Ähnlich wie bei anderen Proteinkinasen kann die Bindung eines Liganden an 
die PAS Domäne die Autophosphorylierung von PASKIN stimulieren, die dann wiederum zu 
einer gesteigerten Zielproteinphosphorylierung führen könnte. In der Hefe wurde gezeigt, 
dass PASKIN unter Stressbedingungen die Speicherung von Glykogen reduziert sowie die 
Proteintranslation vermindert. In Säugetierzellen phosphoryliert PASKIN die Glykogen-
Synthase und scheint glucoseabhängig an der Insulinproduktion von β-Zellen im Pankreas 
beteiligt zu sein.  
PASKIN ist am stärksten in der postmeiotischen Phase der Spermatogenese exprimiert. Von 
uns durch homologe Rekombination erzeugte PASKIN knock-out Mäuse weisen eine normale 
Entwicklung, Wachstum, Fortpflanzung sowie keine Beeinträchtigung der Fruchtbarkeit auf. 
Um die Funktion von PASKIN während der Spermatogenese zu untersuchen, wurde ein 
monoklonaler, gegen die PAS Domäne gerichteter Antikörper hergestellt. Zudem wurde ein 
Zwei-Hybrid Screening mit einer HeLa cDNA Bibiliothek in der Hefe durchgeführt, um 
mögliche Interaktionspartner von PASKIN zu identifizieren. Ein identifiziertes Target von 
PASKIN ist der eukaryotische Translations-Elongationsfaktor eEF1A1, welcher sowohl mit 
der PAS A als auch mit der Kinase Domäne von PASKIN in vitro und in vivo interagiert. Die 
Phosphorylierung von eEF1A1 durch PASKIN an Threonin 432 könnte auf eine Aktivierung 
von eEF1A1 hinweisen, die dann zu einer erhöhten translationellen Elongation führt. 
Tatsächlich sind beide Proteine im Mittelstück des Spermiumschwanzes lokalisiert, was 
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darauf hindeuten könnte, dass die eEF1A1 Phosphorylierung durch PASKIN die 
translationelle Elongation im Spermium reguliert. eEF1A1 wird auch durch die Proteinkinase 
PKCδ phosphoryliert, deren Aktivität durch ein Gemisch aus Phosphatidylserin und 
Diacylglycerol stimuliert wird. Da ein endogener Ligand für die PASKIN Aktivierung bisher 
nicht bekannt ist, haben wir die beiden Kinasen bezüglich ihrer Aktivierung durch Lipide 
untersucht. Zum ersten Mal konnten wir zeigen, dass Phospholipide im Gegensatz zum 
sekundären Botenstoff Diacylglycerol die Autophosphorylierung von PASKIN stimulieren.  
Neu ist auch, dass die durch die Phospholipase D gebildete Phosphatidylsäure mit PASKIN in 
vitro interagiert. Die Tatsache, dass Phosphatidylsäure und nicht das von der Phospholipase C 
gebildete Diacylglycerol an PASKIN bindet, belegt Phosphatidylsäure als Minimaldomäne 
der Phospholipide für die PASKIN Aktivierung. Zusätzlich wird die Autophosphorylierung 
von PASKIN durch Phosphatidylsäure erhöht, gleichzeitig wird aber die eEF1A1 
Targetphosphorylierung inhibiert.  
Über die funktionelle Rolle von PASKIN während der Spermatogenese ist sehr wenig 
bekannt. Daher wurde ein weiteres Zwei-Hybrid Screening mit der Kinase Domäne als 
„Köder“ und einer humanen Hoden cDNA Bibliothek in der Hefe durchgeführt. Wir konnten 
das multifunktionelle Protein Ku70 als einen weiteren Interaktionspartner von PASKIN in der 
Hefe identifizieren. Des weiteren konnte diese Interaktion in einem GST Pull-down 
Experiment in vitro bestätigt werden. Außerdem konnte gezeigt werden, dass Ku70 nicht 
durch PASKIN phosphoryliert wird, auch nicht in der Anwesenheit von Phospholipiden oder 
dem sekundären Botenstoff Diacylglycerol. Die Identifizierung der beiden Interaktionspartner 
eEF1A1 und Ku70 wird in Zukunft dabei helfen, die physiologische Funktion von PASKIN 
besser zu verstehen. 
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3. Summary 
3. SUMMARY 
 
Protein phosphorylation is an important form of posttranslational modification involved in 
cellular signal transduction pathways. Recently, we and others identified a novel mammalian 
serine/threonine kinase that we named PASKIN. PASKIN contains two PAS domains which 
are highly related to the oxygen sensor protein FixL from Rhizobium species. PAS domains 
act as protein sensors that are involved in the perception of light intensity, oxygen partial 
pressure, redox potentials, voltage and concentrations of certain ligands. Additionally, 
mammalian PAS domains serve as dimerization interfaces of transcription factors involved in 
the xenobiotic response, adaptation to hypoxia and circadian rhythm generation. Besides the 
two PAS domains of PASKIN, the catalytic serine/threonine kinase domain is similar to the 
AMP kinases. PASKIN activation appears to be stimulated in a ligand-dependent manner. 
Ligand-binding to the PAS domain of PASKIN stimulates kinase activity, probably resulting 
in target-phosphorylation as is known from other protein kinases. It has been reported that 
under stress conditions PASKIN downstream-target activation decreases glycogen storage 
and protein translation in yeast. PASKIN phosphorylates mammalian glycogen synthase and 
seems to be involved in glucose-stimulated insulin production in pancreatic β-cells.  
PASKIN is highly expressed during the postmeiotic stage of spermatogenesis. PASKIN 
knock-out mice generated by homologous recombination show normal development, growth, 
reproduction and fertility. To elucidate the function of PASKIN, we generated a mouse 
monoclonal antibody against the PAS domain of human PASKIN. Furthermore we performed 
a yeast two-hybrid screening of a HeLa cDNA library to identify novel interaction partners of 
human PASKIN. The eukaryotic translation elongation factor eEF1A1 was identified as target 
of PASKIN. eEF1A1 interacts with the PAS A and the kinase domains of PASKIN in vitro 
and in vivo. We could also demonstrate that eEF1A1 is phosphorylated at Thr 432, probably 
leading to increased translational elongation. Surprisingly, these two proteins showed a 
similar localization in the midpiece of the sperm tail, suggesting that phosphorylation of 
eEF1A1 by PASKIN regulates translational elongation in sperm cells. It is known that the 
protein kinase PKCδ  also phosphorylates eEF1A1 and is maximally stimulated by a mixture 
of phosphatidylserine and diacylglycerol. Because an endogenous ligand for PASKIN 
activation was unknown so far, we compared these two kinases with regard to their activation 
by lipids. We could show that phospholipids but not the second messenger molecule 
diacylglycerol are stimulators for PASKIN activity. The finding that phosphatidic acid 
produced by phospholipase D but not diacylglyerol generated by phospholipase C interacts 
with PASKIN, suggests phosphatidic acid as minimal moiety for PASKIN stimulation. 
Phosphatidic acid enhances PASKIN autophosphorylation. Additionally, we could show that 
phosphatidic acid inhibits eEF1A1 target phosphorylation by PASKIN.  
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To obtain more insights into the functional role of PASKIN during spermatogenesis, a further 
yeast two-hybrid screening using the kinase domain of PASKIN as bait and a human testis 
cDNA library was performed. The multifunctional protein Ku70 was identified as interaction 
partner of PASKIN. This interaction could be confirmed in vitro, but no PASKIN 
phosphorylation of Ku70 took place in the presence of phospholipids or the second messenger 
molecule diacylglycerol. The identification of eEF1A1 and Ku70 as novel PASKIN 
interaction partners will help to elucidate the physiologic function of PASKIN. 
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4. INTRODUCTION 
 
PASKIN – a novel serine/threonine kinase  
 
The combination of protein kinases and protein phosphatases greatly influences regulatory 
processes in the cell. In 1959, it was reported for the first time that phosphorylation/ 
dephosphorylation controls the activity of a protein (glycogen phosphorylase). Over the years 
the role of phosphorylation in regulating protein function became more important [1,2]. Now, 
over 1000 protein kinases are known in vertebrates. The human kinome consists of 518 
protein kinase genes, constituting about 1.7% of all human genes, and they have been 
classified into over 57 families [2]. By database searches using the PAS (PER/ARNT/SIM) 
sequence as bait [3], our and other labs identified a novel serine/threonine kinase belonging to 
the family of PAS proteins, named PASKIN [4] or PASK [5]. Based on the high similarity to 
the AMP kinases, PASKIN is assigned to the family of calcium/calmodulin-dependent 
kinases (Fig. 1).  
 
 
Figure 1: The human kinome. The phylogenetic tree depicts the relationships between members of the complete 
superfamily of human protein kinases (www.cellsignal.com). PASKIN or PASK is assigned to the family of 
calcium/calmodulin-dependent kinases. 
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The domain architecture of PASKIN resembles that of the oxygen sensor protein FixL from 
Rhizobium species which contains a heme-bearing PAS domain and a histidine kinase domain 
that couples sensing to signalling [6]. 
 
PASKIN - a potential oxygen sensing protein? 
 
PAS domain proteins 
 
Most of the PAS proteins are located in the cytoplasm and act as sensor modules for sensing 
changes in light (phytochromes), oxygen (FixL), redox potentials (Aer, NifL, ArcB), voltage-
activated ion channels (HERG) and binding of certain ligands (AhR) for the detection of 
sensory input signals [7-9]. Unlike the PAS proteins of these two-component regulatory 
systems, PAS proteins also serve as heterodimerization interfaces of transcription factors 
involved in xenobiotic response (AhR/ARNT) [10], circadian rhythm (CLOCK/BMAL and 
PER) [11], carbon monoxide signalling (NPAS2/BMAL1) [12], as well as in the regulation of 
response to hypoxia (HIF1,2,3α/ARNT) [13]. PAS domains were identified in over 1100 
proteins in archaea, bacteria and lower eukarya, but only relatively few sensor PAS proteins 
have been reported in mammalian species [4,14,15]. The term PAS is derived from the three 
founding members of the family - PER, ARNT and SIM. The PER protein of Drosophila 
melanogaster represents a central component in the periods of circadian clocks, ARNT is as 
an aryl hydrocarbon receptor nuclear translocator and SIM, a product of Drosophila single-
minded gene, controls the CNS midline cell development (Fig. 3). The PAS domain of these 
three proteins shows a homologous region containing a 270 amino acid stretch of which two 
conserved 50 amino acid domains divided the sequence into PAS A and PAS B [7,8].  
The first 3-dimensional structure of this widespread PAS protein fold was solved for the blue-
light photoreceptor PYP (photoactive yellow protein) of the Ectothiorhodospira halophila 
that represents a structural prototype for the superfamily of all PAS proteins (Fig. 2). The 
typical structure is formed by five-stranded antiparallel β-sheets and several α-helices on one 
side. In Figure 2 three independent PAS-proteins HERG (human eag-related gene) a member 
of the ether a go-go potassium channel family, PYP and the oxygen-sensing protein FixL are 
shown. The three PAS domains are involved in signal transduction and reflect a high degree 
of structural similarity. The three PAS domain proteins are activated by different mechanisms. 
HERG is an ion channel and belongs to the voltage-gated channels controlled by membrane 
potential [16]. In that case no ligand binding is involved in the activation of HERG. 
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Figure 2: Schematic representation of HERG (A), PYP (B) and FixL (C) shows a high degree of structural 
similarity. β-strands are colored in blue, α-helices in red and cofactor ligands in green [17]. 
 
Unlike the HERG PAS domain, PYP as well as FixL are activated by certain ligands. The 
photoreceptor PYP contains a chromophore (4-hydroxycinnamic acid) that is covalently 
bound to a cysteine in the core of this protein. By photon absorption, an isomerisation takes 
place and results in conformational change of the protein surface [17,18]. The bound 
chromophore is not an activating ligand, but an essential co-factor for light perception.  
In case of FixL the heme-cofactor binds to the PAS domain of this protein. The activity of the 
histidine kinase of FixL is controlled by binding of oxygen to the heme-group within the PAS 
domain. 
 
PASKIN is related to the bacterial oxygen sensor FixL 
 
The soil-nitrogen fixing bacteria, Rhizobium and Bradyrhizobium spezies, live in root nodules 
of certain plants, such as soybean, and exhibit a symbiotic association with its host. The 
nitrogen fixation of this bacterium is controlled by two kinases FixL and FixJ; acting as a 
sensor/regulator pair in a two-component system. At low oxygen concentrations, O2 
dissociates from the ferrous iron of the heme-bearing domain, resulting in activation of its 
kinase domain of FixL by autophosphorylation. 
In the presence of ATP the autophosphorylated form of FixL phosphorylates the regulator 
protein FixJ that promotes the expression of nitrogen fixing genes nif and fix as transcriptional 
activator [6,19]. A spin-state mechanism is proposed for FixL. The kinase is activated in an 
unligand ferrous state (Fe2+) of the bound heme; binding of ligands like oxygen, cyanide and  
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carbon monoxide inhibit the kinase activity [20]. Upon ligand binding, a conformational 
change takes place in the structure of the heme active site in a region between the Fα-helix 
and the Gβ-strand, termed the FG loop.  
 
PASKIN contains two PAS domains with higher sequence similarity to FixL than to any other 
known mammalian PAS protein. PASKIN is the first mammalian PAS protein that contains a 
kinase domain and hence could act as an oxygen sensor and signalling protein. However, the 
PAS domain of bacterially expressed PASKIN fragments did not contain a chromophore like 
is observed for purified FixL protein from bacteria [4]. Thus, PASKIN is most likely not an 
oxygen sensor. 
 
 
Figure 3: Three-dimensional structures of the PAS A domain of Homo sapiens (H.s.) PASKIN and the PAS 
domain of Bradyrhizobium japonicum (B.j.) FixL [15]. Amino acids indicated by red balls in the PAS A domain 
of PASKIN denote residues that undergo structural changes upon ligand binding. The iron-containing heme 
group of the oxygen-sensing FixL PAS domain is shown in the pocket of the PAS domain. 
 
The 3-dimensional structure of the PASKIN PAS A domain has recently been resolved (Fig. 
3) and synthetic ligands binding to this domain were identified by a nuclear magnetic 
resonance (NMR)-based screen of a library of over 750 organic compounds [15]. Binding 
compounds to PASKIN possess a hydrophobic character, containing one or two aromatic 
rings with polar groups and a linker. Both ligand binding as well as mutation of the PAS A 
domain result in the activation of the kinase domain. The synthetic ligands identified are 
structurally related to dioxin, known to bind to the PAS domain of aryl hydrocarbon receptor 
(AhR). However, an endogenous ligand of PASKIN has not been identified so far.
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Structure and activation of PASKIN 
 
PASKIN is encoded by a conserved single copy gene that is ubiquitously expressed. The gene 
structure of PASKIN consists of 18 exons (Fig.4). Interestingly, the analysis of the genomic 
structure of human PASKIN and mouse Paskin genes shows the first exon of the PPP1R7 
gene 1.0 kb upstream in the promoter region of PASKIN. PPP1R7 encodes Sds22, a regulator 
of serine/threonine protein phosphatase-1 [21-23]. The open reading frame of human 
PASKIN cDNA encodes a protein with a predicted molecular weight of 144 kDa. PASKIN 
possesses two N-terminal consensus PAS repeats, PAS A and PAS B and a serine/threonine 
kinase in the C-terminal part of that protein. Unlike the high structurally conservation to the 
PAS domain of FixL, the histidine kinase domain weakly matched to exon 10 of PASKIN [4]. 
The amino acid sequence of the catalytic domain of PASKIN is highly related to Snf1 and 
AMPK protein kinases [5,24]. It has been shown that active PASKIN phosphorylates the 
synthetic AMARA peptide in the presence of ATP. This peptide is known as kinase substrate 
of Snf-1 and AMPK [25] 
 
 
Figure 4: Primary structure of human PASKIN. (A) Gene structure of human PASKIN. Exons are indicated by 
grey boxes numbered according to the human sequence [4]. (B) Protein domain structure of PASKIN with 
known phosphorylation sites. 
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Two major autophosphorylation sites are located in the catalytic domain of PASKIN at 
Thr1161 and Thr1165. The Thr1161A mutant as well as the Thr1165 mutant of PASKIN had 
no detectable kinase activity, suggesting that both phosphorylation sites are necessary for 
efficient kinase activity of PASKIN [5]. Analogous phosphorylation patterns have been 
shown for the related AMP-kinase and its yeast homolog Snf1 [26,27]. A mapping of further 
phosphorylation sites on PASKIN resulted in two putative regions in the C-terminal part of 
PASKIN, comprising residues 1270-1286 and 1287-1318. Five serine residues (S1273,-77,-80 
and S1287,-89) have been analysed by changing serine residues to alanine, but different 
variants of mutation show kinetic parameters indistinguishable from the native human 
PASKIN enzyme [5].  
Another phosphorylation site (S116) was identified in the N-terminal region of PASKIN by a 
large scale characterization of HeLa cell nuclear phosphoproteins [28]. The function of 
PASKIN in the nucleus is unknown so far. Recently, it has been shown that PASKIN 
phosphorylates the pancreatic duodenal homeobox protein PDX-1 in vitro [29] and apparently 
inhibits its translocation to the nucleus, suggesting a functional role of PASKIN in the 
nucleus. 
As known from FixL, the PAS A domain of PASKIN represses the kinase activity in cis. [5] 
The structural features of a PAS domain is a typical α/β PAS domain fold, characterized by 
several α-helices and five-stranded antiparallel β-sheets (Fig.3) [15]. NMR analysis provides 
portions of the flexible Fα helices and the FG loop region for a putative interaction site for 
binding and inhibition of the kinase domain [15]. 
 
An existing model of PASKIN activation proposes that in an unbound ligand state, an 
inhibition of the own kinase domain by binding to the FG loop takes place (Fig.5). Rutter and 
colleagues could show that the catalytic activity of the N-terminal mutant of human PASKIN 
was 5 fold higher than the full-length human PASKIN [5]. Additionally, by adding increasing 
amounts of purified PAS A domain, a decrease in the kinase activity takes place. The role of 
the PAS B domain in the regulation of kinase activity is unknown so far. De-repression, 
presumably by binding of small ligands in the hydrophobic core of the PAS A domain, leads 
to conformational changes in the FG loop and results in an autophosphorylation in trans [5]. 
As a consequence, the activated kinase is able to phosphorylate downstream targets of 
PASKIN in the cell. An endogenous ligand for PASKIN activation has not been identified so 
far.  
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Figure 5: Hypothetic model for PASKIN activation by small ligands. No endogenous ligands are known so far. 
[15].  
 
Kinase activation by phospholipids 
 
A classical way to stimulate kinase activity has been shown for the protein kinase PKC which 
is activated by endogenous ligands such as phospholipids. PKC is a calcium- and 
phospholipid-dependent serine/threonine kinase that acts as a central mediator in the nervous 
system and other cell types [30]. PKC is involved in intracellular signals that regulate growth, 
differentiation and apoptosis in the cell. PKC isoenzymes are divided in three subgroups 
according to their structural homology and regulatory properties. The classical PKCs (α, βI, 
βII, γ) can be activated by calcium, diacylglycerol (DAG) and phosphatidylserine (PS). The 
novel PKCs (δ, ε, η, μ and θ) are calcium independent and can be also stimulated by DAG, 
PS and unsaturated fatty acids. Finally, enzyme activity of the atypical PKCs (ζ, λ and ι) is 
enhanced by PS, phosphatidylinositides and unsaturated fatty acids, but is unresponsive to 
calcium and DAG [31]. Two cysteine-rich domains in the N-terminal part of classical and 
novel PKCs were identified as binding site for DAG and phorbolesters, while phorbolesters 
mimic DAG action [32,33]. In the classical model for PKC activation the phospholipase C 
(PLC) is stimulated by G proteins or receptor mediated tyrosine kinases, cleaving PIP2 at the 
inner plasma membrane to generate membrane-bound DAG and IP3 that increase intracellular 
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calcium level. DAG and calcium cause the translocation of PKC from the cytosol to the 
plasma membrane (Fig. 6) [34].  
 
 
Figure 6: (A) Pseudosubstrate inhibits the catalytic domain of PKC (B) When the cysteine-rich C1 domains bind 
to diacylglycerol in the membrane, the pseudosubstrate is pulled from the active site, permitting catalysis. 
Calcium-binding C2 domains help to localize PKC to the membrane (modified from [35]) 
 
Hannun and Bell show that four or more molecules of PS bind cooperatively to PKC in 
combination with only one molecule DAG to maximally activate the serine/threonine kinase 
[36,37]. The unsaturated fatty acid ester groups of PS seem to be partially responsible for the 
activation of PKC. Neither phosphatidylethanolamine nor phosphatidylcholine alone shows a 
stimulation of PKC, but in a mixture with PS an enhanced enzyme activity is observed for 
PKC [38]. Phosphatidylinositol, phosphatidic acid and sphingomyelin are not able to 
stimulate PKC activity [39].  
The protooncogene product Raf-1 is another lipid-dependent kinase, containing a cysteine-
rich domain in the amino terminus of Raf-1 that is able to bind PS in vitro [40]. An interaction 
between Raf-1 and PS leads to a translocation of the protein to the membrane [41,42] and the 
binding of PS is not dependent on the classical PKC coactivators DAG or phorbolesters. In 
interaction studies from Gosh and colleagues showed that of all tested lipids phosphatidic acid 
and cardiolipin strongly interact with Raf-1. In vivo, the formation of PA by the 
phospholipase D (PLD) is inhibited by 1% ethanol that blocks the translocation of the Raf-1 
kinase from the cytosol to the membrane [41].  
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Further proteins interacting with PS are involved in the retrieval of synaptic vesicle in nerve 
terminals (dynamin I) [43], necrosis (Hsp70 family) [44], specific hydrolysis of 
phosphatidylserine (phospholipase A1) [42] and stress–induced ceramide generation in the 
brain (neutral sphingomyelinase) [45,46]. 
 
Phospholipids 
 
Phospholipids consist of four components: fatty acids, a negatively-charged phosphate group, 
alcohol and a backbone. The phospholipids are divided in two classes by the structure of their 
backbones: phosphoglycerides and sphingomyelin. 
A phosphoglyceride is composed of fatty acyl side chains that are esterified to two hydroxyl 
groups in glycerol and the third hydroxyl group is esterified to phosphate. The phosphate 
group forms a connection by esterification to a hydroxyl group of another hydrophilic 
compound such as choline in phosphatidylcholine. Instead of choline, ethanolamine, serine, 
and the sugar derivative inositol are bound to phosphate in other phosphoglycerides.  
Sphingomyelin is a phospholipid that contains instead of a glycerol backbone an amino 
alcohol with a long unsaturated hydrocarbon chain also termed sphingosine. The terminal 
hydroxyl group of sphingomyelin is esterified to a phosphocholine.  
Phospholipids are characterized as amphipathic molecules containing a hydrophilic and a 
hydrophobic part. The negative charge on the phosphate as well as the charged group or 
hydroxyl group interacts strongly with water. In aqueous solution, phospholipids are able to 
form micelles, liposomes and lipid bilayers. The fatty acyl chains aggregate by hydrophobic 
interactions and exclude water molecules from the inner lumen of this aggregate [47].  
Micelles form spontaneously with a hydrophobic interior composed entirely of fatty acyl 
chains. Unlike micelles, liposomes are arranged in a bilayer structure containing an aqueous 
center. A phospholipid bilayer, as is known from all biological membranes, has a hydrophobic 
core and separates two aqueous solutions [47]. The lipid composition of a typical nucleated 
mammalian cell is shown in table 1. The most abundant phospholipid is phosphatidylcholine 
with 40-50% of total phospholipids in the eukaryotic cell. Phosphatidylethanolamine, 
phosphatidylserine, phosphatidylinositol and sphingomyelin are also present in significant 
amounts. The composition of phospholipids varies in different tissues and different cell types. 
Phosphatidylserine is enriched more than 36% in the brain compared to other tissues. [48] 
Lower levels of PS are present in mitochondrial inner membranes and lysosomes than in other 
membranes such as the endoplasmic reticulum, nucleus and plasma membrane.  
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Interestingly, phosphatidylserine is the most abundant protein in the cell membrane in yeast 
comprising 34% of all phospholipids. The biological significance of this enrichment in yeast 
is unknown so far. Unlike PS, phosphatidylethanolamine is more abundant in mitochondria 
than in other tissues [46]. 
 
 
Table 1: Lipid composition of typical nucleated mammalian cell [46] 
 
Phospholipases such as PLC and PLD are enzymes that play an important role in the 
formation of phospholipids hydrolyzing various bonds in the head group of phospholipids 
[47]. Extracellular signals such as PMA (phorbol 12-myristate 13- acetate) often activate PLD 
[49,50]. The mechanism how PMA activates PLD in vivo is so far unknown [51]. It has been 
shown in vitro that PKC is able to interact with PLD and activates it in an ATP-independent 
manner [52]. PLD generates phosphatidic acid by hydrolysis of phosphatidylcholine or other 
phospholipids [53-55]. Phospholipids are able to interact with enzymes and can stimulate 
kinase activity resulting in downstream-target activation such as it is known for Raf kinases.  
 
The functional role of PASKIN  
 
Targets of PASKIN in yeast 
 
The first insights into target identification of PASKIN were obtained for the yeast PASKIN 
homologs PSK1 and PSK2. Under stress conditions, the psk1 psk2 double-mutant strain 
shows a decreased growth at elevated temperature (39°C) and galactose supply. Two enzymes 
have been identified which are involved in the regulation of glycogen and trehalose synthesis. 
The UDP-glucose pyrophosphorylase (Ugp1) catalyzes the conversion of glucose-1-P to 
UDP-glucose which is inhibited by Psk2 phosphorylation. The other enzyme the glycogen 
synthase 2 (Gsy2), adds glucose monomers to glycogen by release of UDP and is also 
inhibited by efficient phosphorylation by Psk2. The negative regulation of Ugp-1 and Gsy2  
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suggests that PASKIN plays a role in the switch of glycogen storage in favour of glycolysis 
[56]. Recently, it has been shown that the mammalian glycogen synthase interacts with the 
midregion of human PASKIN and is phosphorylated at Ser-640 [57]. 
A second biological function of PASKIN in yeast is based on the identification of three 
further phosphorylation targets in yeast: Caf20, Tif11 and Sro9. They promote several steps 
of protein synthesis. The Cap-associated factor 20 (Caf20) is a small protein termed p20 that 
blocks the association of the mRNA cap-binding protein, eukaryotic translation initiation 
factor eIF4E and eIF4G. p20 and eIF4G bind competitively to eIF4E [58]. Rutter et al. show 
that Caf20 in complex with eIF4E was efficiently phosphorylated by Psk2, but interestingly 
neither of them was phosphorylated alone by Psk2 [5].  
The second phosphorylation target Tif11 is the yeast ortholog of eukaryotic translation 
initiation factor 1A (eIF1A) that mediates the transfer of aminoacyl-tRNA to the 40S 
ribosomal subunit [59].  
The third Psk2 substrate, the RNA binding protein Sro9, is associated with translation-active 
ribosomes [60] and is also involved in the organization of actin filaments [61]. In summary, 
the yeast PASKIN homologs phosphorylate three translation factors and two enzymes 
involved in the regulation of glycogen and trehalose synthesis, thereby coordinately 
controlling translation and sugar flux [56].  
 
High expression of PASKIN during spermatogenesis 
 
To elucidate the function of mammalian PASKIN, our lab previously inactivated the mouse 
Paskin gene by homologous recombination in embryonic stem cells [14]. The replacement of 
exon 10 to 14 by a lacZ reporter gene was used for the identification of cell types expressing 
mouse PASKIN by X-Gal staining. Paskin-/- mice showed normal development, growth and 
reproduction. By Northern blot analysis of mouse organs PASKIN mRNA expression was 90-
fold higher in testis than in the thymus, the organ with the second highest PASKIN mRNA 
expression. Very low levels of PASKIN mRNA expression were observed for the other 
tissues such as the brain, lung and liver [14]. 
Da Silva Xavier et al. suggested that PASKIN kinase activity, mRNA and protein expression 
is upregulated in MIN6 cells and in isolated pancreatic β-cells after treatment with high 
glucose concentrations [62]. In a recent report, our lab could show that PASKIN mRNA 
induction is not induced in MIN6 or in pancreatic β-cells. Increasing glucose concentrations 
lead to induction of insulin mRNA levels and insulin release, but independent of PASKIN  
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mRNA expression or protein levels. Analysis of blood glucose levels and glucose tolerance 
test show no differences between Paskin wildtype and knock out mice [63]. X-Gal stainings 
for β-galctosidase reporter gene activity showed a high PASKIN level in the seminiferous 
tubuli of mouse testis [14,63]. No other tissue, including ovary and uterus, revealed any blue 
color staining, suggesting that the testis is the main organ for PASKIN expression. X-Gal 
stainings and in situ hybridization by silver grain visualization of mouse testis section 
revealed PASKIN expression in spermatocytes, spermatids and spermatozoa, but not in 
spermatogonia or Leydig cells. PASKIN expression is strongly upregulated in postmeiotic 
spermatids suggesting an involvement of PASKIN in sperm cells after leaving the testis. 
However, the absence of PASKIN affects neither male fertility nor sperm production or 
motility [14].  
 
Downstream targets of PASKIN in mammals 
 
The eukaryotic translation elongation factor eEF1A1 
 
To get more insight into the function of PASKIN, we identified eEF1A1 as protein-protein 
interaction partner of PASKIN in a yeast two-hybrid screening with the PAS sequence of 
PASKIN as bait and a HeLa cDNA library elongation factor. eEF1A1 is an ubiquitously 
expressed GTP-binding protein. Another isoform, eEF1A2, is highly expressed in the heart, 
brain and skeletal muscle, but was not detectable in other tissues like liver, lung, kidney, 
placenta and pancreas [64]. Interestingly, eEF1A1 is barely expressed in heart and skeletal 
muscle, suggesting a tissue-dependent variation in the expression of both isoforms [65]. 
eEF1A is one of many different factors which are involved in the elongation step of protein 
biosynthesis. The elongation cycle of the protein biosynthesis is shown in figure 7. There, 
eEF1A in complex with GTP and aminoacyl-tRNA mediates the binding of the tRNA to the 
A-site of the ribosome. Upon placement of the aminoacyl-tRNA, GTP hydrolysis takes place 
and results in the dissociation of eEF1A and GDP from the ribosome. The eEF1B complex 
(α, β, γ) stimulates the conversion of the inactive form of eEF1A by a GDP/GTP exchange, 
starting another round of tRNA binding and recruitment. In the translocation phase of protein 
synthesis, first a peptide bound is formed between the amino acids at the P and A site of the 
ribosome. In a second step, eEF2 mediates the translocation of the peptidyl-tRNA from the A 
site to P sites by hydrolysing GTP. The previous peptidyl-tRNA changes from the P to the E 
site and is finally released. The ribosome moves the distance of three nucleotides of  
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the mRNA to reach the next codon. Upon release of eEF2-GDP the translocation process is 
finished and the A site is free for a new aminoacyl-tRNA transferred by eEF1A.  
 
 
Figure 7: Scheme of the elongation cycle of eukaryotic protein synthesis. (A) eEF1A transfers aminoacyl-tRNA 
to the A-site of the ribosome. GTP hydrolysis allows eEF1A to dissociate from the ribosome and bind to the 
eEF1B complex. GTP/GDP exchange is mediated by this complex starting another round of recruitment of 
tRNA. (B) A peptide bound is formed between the amino acids from the P and A sites. eEF2 binds at the A site 
of the ribosome and induces the translocation of three nucleotides towards 3’-end of the mRNA by hydrolysis of 
GTP. After dissociation of eEF2 from the ribosome, the A site is left free for a new transferred tRNA (modified 
from [66]). 
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Insulin and phorbol esters are able to stimulate the phosphorylation of eEF1A1 in vivo. 
[67,68]. Chang and colleagues have shown that the multipotent S6 kinase is primarily 
responsible for the phosphorylation of eEF1A1 after insulin treatment [69]. In response to the 
tumor promoting phorbol ester PMA, eEF1A1 is phosphorylated by PKC in vitro and in vivo 
[67,68]. PKC isoforms such as PKCα, β and γ are also able to phosphorylate eEF1A1, but 
PKCδ was the most efficient isoform of all tested PKCs. Kielbassa et al. identified PKCδ 
phosphorylation of eEF1A1 at Thr431 [70].  
In addition to protein synthesis, eukaryotic EF1A1 has been shown to be involved in other 
cellular processes such as cell growth, stress response or motility [71]. An involvement of 
eEF1A in phosphoinositide pathway is confirmed by an interaction with PLCγ−1 in vitro and 
in vivo. The interaction partner was found by yeast two-hybrid screening of a human B-
lymphocyte library. After EGF treatment, the interaction between eEF1A and PLC-γ1 was 
increased, suggesting an involvement of eEF1A in PLCγ-mediated signal transduction. [72]  
Furthermore, eEF1A was identified as a phosphorylation target of the plant chimeric calcium / 
calmodulin-dependent protein kinase (CCaMK) that phosphorylates a threonine residue 
within a region of the putative aminoacyl-tRNA binding site in a calcium- and calmodulin-
dependent manner [73]. The phosphorylation of eEF1A by CCaMK has been shown to reduce 
actin-bundling activity [74]. Interactions of eEF1A with the actin cytoskeleton were first 
observed in Dictyostelium amoebae and this function could be confirmed across species from 
yeast to mammals. In yeast, the actin bundling by eEF1A is not necessary for translation, 
unlike the mammalian system where a disruption of actin cytoskeleton leads to a reduced 
translation [75,76]. These observations suggest a different function of actin in different 
eukaryotic species [77]. A link between eEF1A and actin cytoskeleton has also been shown in 
cancer, supporting the requirement of the actin cytoskeleton for metastasis [78]. Eukaryotic 
EF1A mRNA expression is highly upregulated in human pancreas, colon, breast, lung and 
gastric tumors [79]. Increasing amounts of eEF1A protein expression were observed in 
metastatic tumor cells leading to a reduced binding to F-actin. After stimulation with 
epidermal growth factor (EGF) F-actin as well as eEF1A protein expression was remarkably 
enhanced, indicating a redistribution of EF1A into the actin cytoskeleton in tumor cells [78]. 
The eukaryotic EF1A seems to be also involved in apoptosis. Studies with a temperature-
sensitive mutant of p53 have shown an upregulation of eEF1A [80]. After treatment with 
hydrogen peroxide, increased levels of endogenous eEF1A were observed in cardiomyocytes, 
suggesting an involvement of eEF1A in apoptosis in response to oxidative stress [81,82].  
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The DNA-repair protein Ku70 as a putative interaction partner of PASKIN
 
To verify the functional role of PASKIN in the testis, a second yeast two-hybrid screening 
with a human testis cDNA library and the kinase domain of PASKIN as bait revealed the 
DNA repair protein Ku70 as an interaction partner of PASKIN.  
Ku70 is a multifunctional protein mainly involved in DNA-repair. Numerous reports 
implicate Ku70 in other cellular processes, including V(D)J recombination, antigen-receptor-
gene rearrangements, mobile-genetic element biology, telomere maintenance, apoptosis and 
transcription [83]. It has been reported that the Ku complex is localised in not only nuclei but 
also cytoplasm [84-86]. In eukaryotes, Ku is a stable heterodimer consisting of two subunits 
with 70 and 80 kDa, named Ku70 and Ku80. Each Ku subunit possesses a von Willebrand A 
domain (vWA) in the N-terminus and a central core domain (Fig. 8).  
 
Figure 8: Domain organization of Ku80 and Ku70 protein. Ku proteins consist of a von Willebrand A domain 
(vWA), a central core domain. In the C-terminus, Ku80 contains a binding site for DNA-PKcs and Ku70 
possesses a SAP motif with an unknown function [83].  
 
The von Willebrand A domain acts as protein-protein interaction site. Interestingly, Ku70 has 
a SAP domain in the carboxy-terminal region which is named after three proteins containing a 
typical SAF-A/B, Acinus and PIAS motif. This motif is derived from a helix-extension-helix 
fold [87]. The function of this domain is unknown so far. In Ku80 the carboxy-terminal 
region is longer and contains a binding site for DNA-PKCS [83]. A model for the formation of 
the Ku-DNA-DNA-PK complex suggests that after heterodimerization of Ku70 and Ku80 the 
DNA is bound in an asymmetric ring of the Ku-complex [88] and creates a binding substrate 
for DNA-PKCS. In this Ku-DNA complex the kinase activity of DNA-PKCS is stimulated and 
it phosphorylates downstream targets that are involved in DNA-repair such as tumor 
suppressor protein p53, Fos, Sp1, H2AX and RNA-polymerase II [89,90].  
The autophosphorylation of DNA-PKCS leads to a dissociation of DNA-PKCS from Ku-DNA 
complex [83].  
 25
4. Introduction 
In conclusion, in mammals the PDX-1, the glycogen synthase, eEF1A1 as well as the putative 
interacting protein Ku70 were identified as downstream targets of PAKSIN. The above 
discussed targets of PASKIN in yeast and mammals suggest a possible role of PASKIN as 
multifunctional protein that is involved in many cellular processes such as protein translation, 
sugar flux, apoptosis and actin cytoskeleton bundling. 
 
Goal of this thesis 
 
The goal of this thesis was to identify novel interacting proteins derived from the testis which 
interact with PASKIN. An initial yeast two-hybrid screening with a HeLa cDNA library 
revealed the eukaryotic translation elongation factor EF1A1 as a novel interaction partner of 
PASKIN. To obtain more insights into the functional role of PASKIN during the 
spermatogenesis, we performed a second yeast two-hybrid screening with a human testis 
cDNA library. The discovered protein-protein interactions of PASKIN with emphasis on the 
eukaryotic translation elongation factor eEF1Α1 have to be confirmed in vitro and functional 
assays are required. It is known that synthetic ligands bind to PASKIN, but an endogenous 
ligand for PASKIN activation is unknown so far. Therefore, another goal of the thesis was to 
identify endogenous ligands that trigger PASKIN stimulation, leading to the activation of 
target phosphorylation. The identification of such an activator would be of high importance in 
the studies of PASKIN characterization. 
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ABSTRACT 
 
PASKIN links energy flux and protein synthesis in yeast, regulates glycogen synthesis in 
mammals, and has been implicated in glucose-stimulated insulin production in 
pancreatic β-cells. Using newly generated monoclonal antibodies, PASKIN was localized 
in the nuclei of human testis germ cells and in the midpiece of human sperm tails. A 
speckle-like nuclear pattern was observed for endogenous PASKIN in HeLa cells in 
addition to its cytoplasmic localization. By yeast two-hybrid screening, we identified the 
multifunctional eukaryotic translation elongation factor eEF1A1 as a novel interaction 
partner of PASKIN. This interaction was mapped to the PAS A and kinase domains of 
PASKIN and to the C-terminus of eEF1A1 using mammalian two-hybrid and GST pull-
down assays. Kinase assays, mass spectrometry and site-directed mutagenesis revealed 
PASKIN auto-phosphorylation as well as eEF1A1 target phosphorylation mainly but not 
exclusively at Thr432. Wild-type but not kinase-inactive PASKIN increased the in vitro 
translation of a reporter cRNA. Whereas eEF1A1 did not localize to the nucleus, it co-
localizes with PASKIN to the cytoplasm of HeLa cells. The two proteins also showed a 
remarkably similar localization in the midpiece of the sperm tail. These data suggest 
regulation of eEF1A1 by PASKIN-dependent phosphorylation in somatic as well as in 
sperm cells.  
 
 
INTRODUCTION 
 
Physiological adaptations of an organism to changing environmental conditions require 
molecular sensors capable of sensing and signalling specific physico-chemical parameters. 
The PAS (Per-Arnt-Sim) domain is a widespread protein fold of environmental protein 
sensors involved in the perception of light intensity, oxygen partial pressure, redox potentials, 
voltage and certain ligands [1]. In mammals, the PAS domain is mainly found as a 
heterodimerization interface of transcription factors involved in the molecular circadian clock, 
dioxin toxicity and oxygen sensing [2-4]. 
We and others previously identified a novel mammalian PAS protein, termed PASKIN [5] or 
PAS kinase [6]. The domain architecture of PASKIN resembles that of the oxygen sensor 
protein FixL from nitrogen-fixing Rhizobium species. PASKIN contains two PAS domains 
(PAS A and PAS B) and a serine/threonine kinase domain related to AMP kinases which 
might be regulated in cis by binding of so far unknown ligands to the PAS domain [7]. 
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Following de-repression, autophosphorylation in trans results in the "switch-on" of the kinase 
domain of PASKIN [6]. The budding yeast PASKIN homologs PSK1 and PSK2 
phosphorylate three translation factors and two enzymes involved in the regulation of 
glycogen and trehalose synthesis, thereby coordinately controlling translation and sugar flux 
[8]. Under stress conditions (nutrient restriction combined with high temperature), PASKIN 
kinase activity results in increased protein synthesis and decreased carbohydrate storage in 
yeast. PASKIN-dependent phosphorylation also inhibits the activity of the mammalian 
glycogen synthase [9]. In addition, a recent report suggested that PASKIN expression as well 
as kinase activity is increased in isolated pancreatic β-cells following stimulation with high 
glucose levels [10]. Increased PASKIN activity appeared to be required for glucose-
dependent transcriptional induction of preproinsulin gene expression, which might be related 
to PASKIN-dependent regulation of the nuclear import of pancreatic duodenal homeobox-1 
transcription factor [11]. 
We recently generated PASKIN null mice by targeted replacement of the kinase domain of 
the mouse Paskin gene by a lacZ-neo fusion construct in embryonic stem cells [12,13]. 
Surprisingly, PASKIN expression is strongly upregulated in post-meiotic germ cells during 
spermatogenesis as revealed by in situ hybridization, β-galactosidase staining and mRNA 
blotting. In fact, PASKIN mRNA levels in testis are several magnitudes higher than in all 
other organs tested. However, at least under laboratory conditions, fertility as well as sperm 
production and sperm motility were not affected in PASKIN knock-out mice. No other 
organs, including pancreas, stained positive for β-galactosidase, and we could not detect any 
PASKIN-dependent insulin regulation [14].  
To obtain more insights into PASKIN function, we generated specific monoclonal antibodies 
derived against PASKIN and screened a HeLa cDNA expression library in a yeast two-hybrid 
system to identify novel PASKIN interaction partners in mammals. Here we show that the 
eukaryotic translational elongation factor eEF1A1 interacts with PASKIN. eEF1A1 is a GTP-
binding protein catalyzing the binding of charged aminoacyl-tRNA to the A-site of the 
ribosome [15-17]. eEF1A1 is of particular interest because it is related to the yeast translation 
initiation factor eIF1A that mediates the transfer of Met-tRNA to the 40S subunit of the 
ribosome, and which was shown to be regulated by the yeast PASKIN homologs PSK1 and 
PSK2 [8].  
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MATERIALS AND METHODS 
 
Plasmids 
 
If not indicated otherwise, cloning work was carried out using Gateway technology 
(Invitrogen, Basel, Switzerland). pcDNA3hPASK [6], containing wild-type or mutant human 
PASKIN cDNA (kindly provided by J. Rutter, Salt Lake City, UT, USA), was digested with 
NcoI (all restriction enzymes were purchased from MBI Fermentas, Labforce, Nunningen, 
Switzerland), blunted with Klenow polymerase and subcloned into SalI-EcoRV-blunted 
pENTR4 (Invitrogen) to obtain pENTR4hPASK. The PAS domain plasmid pENTR4PAS was 
obtained by BamHI digestion and re-ligation of pENTR4hPASK. The kinase (KIN) domain 
plasmid pENTR4KIN was obtained by subcloning the Ecl136II fragment of pcDNA3hPASK 
into the XmnI-EcoRV sites of pENTR4. Other fragments of PASKIN were amplified by PCR 
using Pfu polymerase (MBI Fermentas), digested with NcoI and XhoI and subcloned into the 
same sites of pENTR4. The following primers (synthesized by Microsynth, Balgach, 
Switzerland) were used: PAS A (5'-catgccatggtaagtgtgtcctgctgctccct-3' and 5'-
ctagctcgagttactgccgcatcctcttcatcc-3'); PAS B (5'-catgccatggcttgggtgttctgcaccatc-3' and 5'-
ctagctcgagttaggccaggtctgggagctgta-3'); N-terminal (5'-caggacgcccgccataaact-3' and 5'-
ctagctcgagttatgaggaccaccctg-3'); centerpiece (5'-catgccatggagatccgaaagctgatggaa-3' and 5'-
ctagctcgagttactcagcagcggtagagtgg-3'). pENTR4PASA1/2 was obtained by digesting 
pENTR4PASKIN with BamHI and HindIII, Klenow fill-in and re-ligation. The plasmid 
pCMV6-XL5-eEF1A1, containing the full-length human eEF1A1 cDNA, was purchased from 
OriGene (Rockville, MD, USA). eEF1A1 was amplified by PCR (full-length: 5'-
catgccatgggaaaggaaaagactcatatc-3' and 5'-ctagctcgagccgttcttccaccactgatt-3'; 1-241: 5'-
aagcagaaggccatcctgac-3' and 5'-ctagctcgagttatggacgagttggtggtagga-3'; 247-462: 5'-
catgccatggtgcgcctgcctctccaggat-3' and 5'-gatatctcgagccgttcttccac-3') and subcloned into 
pENTR4 as above. The T432A mutation was introduced by Pfu polymerase-based site-
directed mutagenesis using the primer 5'-cgtgatatgagacaggctgttgcggtgggtg-3', followed by 
DpnI digestion of the parental strain. The inserts of all ENTRy vectors were verified by DNA 
sequencing (Microsynth). To generate expression vectors for fusion proteins, ENTRy vectors 
were recombined in vitro with DESTination vectors using LR Clonase recombination enzyme 
mix (Invitrogen). pDEST15 and pDEST17 were used to generate bacterial or rabbit 
reticulocyte lysate expression vectors for GST- and His6-fusion proteins, respectively. 
pDEST10 and pDEST20 were used to generate expression vectors for His6- and GST-fusion 
proteins, respectively, in the baculovirus/Sf9 insect cell system (Invitrogen). pcDNA3.1/nV5-
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DEST was used to express N-terminal V5-tagged proteins in mammalian cells or in rabbit 
reticulocyte lysates.  
 
 
Generation of monoclonal antibodies 
 
GST-PAS fusion protein expression was induced in E. coli BL21-AI by 0.2% arabinose for 4 
hours and affinity purified with glutathione sepharose (Amersham Biosciences, Dübendorf, 
Switzerland). Two mice were immunized with this antigen using standard procedures. 
Hybridoma cell lines were established and culture supernatant tested against the antigen, or 
GST alone, by ELISA and immunoblotting. Antibodies from positive hybridoma supernatants 
were purified using protein A agarose (EconoPac protein A cartridge, BioRad, Reinach, 
Switzerland) liquid chromatography. Antibody isotyping was performed using ISOstrip 
mouse strips (Roche Diagnostics, Mannheim, Germany). 
 
 
Immunoblotting 
 
Combined cytoplasmic and nuclear extracts of cultured cells were prepared using 0.4 M NaCl 
and 0.1% NP-40 in extraction buffer as described previously [18]. Nuclear extracts were 
prepared from isolated nuclei using 0.4 M NaCl. Protein concentrations were determined by 
the Bradford method using bovine serum albumin as a standard. For immunoblot analysis, 
cellular protein was electrophoresed through SDS-polyacrylamide gels and electrotransferred 
onto nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany) by semi-dry 
blotting. Membranes were stained with Ponceau S (Sigma) to confirm equal protein loading 
and transfer. The following antibodies were used: mouse monoclonal antibody (mAb) anti-
(α)Gal4 and mAb αVP16 (Santa Cruz Biotechnology, Heidelberg, Germany); mAb αeEF1A1 
(Stressgen, Biomol, Hamburg, Germany); mAb αV5 tag (Invitrogen); mAb αHis6 tag 
(Abcam, Cambridge, UK); rabbit polyclonal α β-actin (Sigma); and secondary polyclonal 
goat anti-mouse or anti-rabbit antibodies coupled to horseradish peroxidase (Pierce, Perbio, 
Lausanne, Switzerland). Chemiluminescence detection was performed by incubation of the 
membranes with 100 mM Tris-HCl pH 8.5, 2.65 mM H2O2, 0.45 mM luminol and 0.625 mM 
coumaric acid (all purchased from Sigma, Buchs, Switzerland) for 1 minute followed by 
exposure to X-ray films (Fuji, Düsseldorf, Germany). Alternatively, the Supersignal West  
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Dura kit (Pierce) was used and chemiluminescence was recorded with a CCD camera 
(FluorChem8900, AlphaInnotech, Witec, Littau, Switzerland). 
 
 
Immunohistochemistry 
 
Paraffin-embedded human testis samples (tumor orchidectomy) were sectioned (2 μm) and 
antigen retrieved by boiling the sections in 0.1 M citrate buffer for 90 minutes. Peroxidase 
activity was blocked by incubating with 3% H2O2 and unspecific binding sites were blocked 
with protein-block (Dako, Hamburg, Germany). The slides were incubated with αPASKIN 
mAb2 or mAb6, or αeEF1A1 mAb, diluted 1:50 and 1:100, respectively, in 50 mM Tris-HCl 
pH 7.6, 0.5 M NaCl, 0.1% Tween 20, 10% FCS for 15 minutes. Following washing, primary 
antibodies were detected with the CSA enhancing system (Dako) and DAB (for PASKIN) or 
FastRed (for eEF1A1) substrates. PASKIN production in SF9 was detected as described 
above except that the Envision system (Dako) with FastRed as chromogen was employed. All 
slides were counterstained with hemalaun. 
 
 
Immunofluorescence 
 
Collection of human ejaculated spermatozoa was approved by the ethics committee of the 
University of Leipzig (approval number 067-2005). Spermatozoa were washed in PBS, 
streaked onto microscope slides, incubated for 5 minutes in demembranization buffer (2% 
Triton-X100, 5 mM DTT, 50 mM Tris-HCl pH 9.0) and fixed with 3% paraformaldehyde. 
The non-specific binding sites were blocked with 3% BSA in PBS for 30 minutes. 
Spermatozoa were incubated for 1 hour with αPASKIN mAb2 or mAb6 diluted 1:10 in 3% 
BSA in PBS followed by a TexasRed-coupled secondary anti-mouse antibody (Dako) or an 
AlexaFluor 488-coupled secondary anti-mouse antibody (Invitrogen) diluted 1:100 with 3% 
BSA in PBS. HeLa cells were grown on cover slips and treated accordingly. Finally, nuclei 
were stained with Hoechst33258 dye for 5 minutes. After extensive washings with PBS, the 
slides were mounted and analyzed by fluorescence microscopy (Axioplan 2000, Carl Zeiss 
Vision, Mannheim, Germany) or confocal microscopy (LSM510, Carl Zeiss Vision). 
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Cell culture, transient transfection and co-immunoprecipitation 
 
Human Hep3B hepatoma, HeLa cervical carcinoma and NCCIT male germ tumor (kind gift 
of S. Schweyer, Göttingen, Germany) cell lines were cultured in high glucose Dulbecco's 
modified Eagle's medium (Sigma) as described previously [19]. Transient transfection was 
performed with the polyethylenimine (PEI; Polysciences, Warrington, PA, USA) method. 
Therefore, 3 μg DNA in 100 μl 150 mM NaCl was mixed with 15 μl 1 mg/ml PEI stock 
solution in H2O and 85 μl 150 mM NaCl. Following 30 minutes incubation at room 
temperature, the mixture was added to 50% confluent cells on a 10 cm dish and incubated for 
24 hours. As determined by transient transfections with the green fluorescent protein 
expression vector pEGFP-C1 (Clontech, BD Biosciences, Heidelberg, Germany), transfection 
efficiency usually was 60-80% with this method (data not shown). For co-
immunoprecipitation, pre-cleared cell extracts were incubated with αPASKIN mAb6 
covalently coupled to sepharose A beads [20]. The beads were washed with 0.5% NP-40, 50 
mM Tris-HCl pH 7.5, 250 mM NaCl, 5 mM EDTA and bound proteins were analyzed by 
immunoblotting. 
 
 
Yeast two-hybrid 
 
A HeLa cell-derived cDNA library was screened using the PAS domain of human PASKIN as 
bait according to the instructions provided by the manufacturer (Clontech). Therefore, the 
full-length human PASKIN cDNA clone pDKFZp434O1522 [5] was digested with NcoI and 
SmaI and the cDNA fragment inserted into the NcoI-SmaI sites of the pAS2 vector 
(Clontech). Subsequently, the C-terminal part was deleted by BamHI digestion and re-ligation 
to obtain pAS2PAS. 
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Mammalian two-hybrid 
 
The mammalian Matchmaker vectors pM and pVP16 (Clontech) were converted to 
DESTination vectors by ligation of the Gateway vector conversion cassette reading frame B 
(Invitrogen) into the EcoRI sites (blunted with Klenow polymerase) of pM and pVP16 to 
obtain pMGAL4BDattb and pVP16ADattb, respectively. Mammalian expression vectors for 
Gal4 DNA-binding domain (BD) or VP16 activation domain (AD) fusion proteins were 
obtained after in vitro recombination with the corresponding ENTRy vectors. The pG5FL 
firefly luciferase reporter gene vector was obtained by replacing the SalI-XbaI SEAP cDNA 
fragment from pG5SEAP (Clontech) with the SalI-XbaI luciferase cDNA amplified by PCR 
(primers 5'-gatccgtcgactctagcatggaagacgccaaaaaca-3' and 5'-gctctagaattacacggcgatctttcc-3') 
from pGL3Basic (Promega, Madison, WI). Hep3B cells were transiently co-transfected with 
the BD and AD fusion protein vectors, the firefly luciferase reporter vector and the pRL-
SV40 renilla luciferase reporter vector (Promega) to control for differences in transfection 
efficiency. Luciferase reporter gene activity was determined as described before [21]. Ratios 
between firefly and renilla luciferase activities were normalized to negative control co-
transfections with the pM-53 and pVP16-CP vectors (Clontech) which were arbitrarily 
defined as 1. 
 
 
In vitro transcription/translation (IVTT) and GST pull-down 
 
IVTT reactions were carried out as described by the manufacturer (Promega) using 
recombined DESTination vectors in the presence of 35S-Met (Hartmann Analytic, 
Braunschweig, Germany). For translation assays, separate IVTT reactions (1 μl), containing 
the pDEST17 expression vector alone, β-galactosidase expressing lacZ expression vector, 
wild-type or mutant PASKIN, were mixed with fresh reticulocyte lysate (12.5 μl) and 12.5 ng 
renilla luciferase cRNA (Promega). Luciferase activity was determined as above. GST-tagged 
proteins or GST alone were expressed in E. coli BL21-AI by induction with 0.2% arabinose 
for 4 hours and affinity purified using glutathione sepharose columns (GSTrap FF, Amersham 
Biosciences) by liquid chromatography (BioLogic DuoFlow, BioRad). Pull-down 
experiments were performed by mixing either purified proteins or 20 μl wheat germ IVTT 
reactions with 10 μg purified GST-tagged proteins or GST alone bound to glutathione 
sepharose beads.  
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After 30 minutes incubation at room temperature in bead binding buffer (50 mM Tris-HCl pH 
8.0, 1 mM EDTA, 1 mM DTT, 150 mM NaCl, 0.01% NP40), beads were washed 3 times 
with washing buffer (50 mM Tris-HCl pH 8.0, 1 mM EDTA, 1 mM DTT, 150 mM NaCl, 
0.5% NP40), boiled in sample buffer (40 mM Tris-HCl pH 6.8, 1% SDS, 50 mM β-
mercaptoethanol) for 5 minutes and the proteins separated by SDS-PAGE. Gels were stained 
with coomassie blue, dried and radioactively labelled proteins detected by phosphorimaging 
(Molecular Imager FX, BioRad). 
 
 
Kinase assays and mass spectrometry 
 
His6-PASKIN was purified from baculovirus-infected Sf9 insect cells using Ni-NTA agarose 
(Qiagen, Basel, Switzerland). His6-PASKIN was incubated with 2 μg bacterially expressed 
and purified GST-tagged eEF1A1 (full-length or fragments) or GST alone in 25 mM Tris-HCl 
pH 8.0, 10 mM MgCl2, 1 mM DTT for 20 minutes in the presence of 5 μCi (γ-33P)ATP 
(Hartmann Analytic). Proteins were separated by SDS-PAGE and analyzed by 
phosphorimaging of the dried gels. To determine the phosphorylation site, GST-eEF1A1 was 
incubated with ATP and PASKIN, separated by SDS-PAGE and excised from the gel. One 
third of the gel band was cut into small pieces and washed twice with 100 μl 100 mM 
NH4HCO3, 50% acetonitrile and once with 50 μl acetonitrile. GST-eEF1A1 was digested in-
gel with 30 μl trypsin solution (modified trypsin, Promega, 10 fg/μl in 50 mM Tris-HCl pH 
8.2, 2 mM CaCl2) at 37°C over night. The supernatant was removed and the gel pieces were 
extracted twice with 100 μl 0.1% TFA, 50% acetonitrile. All three supernatants were 
combined in autosampler vials, dried, and dissolved in 10 μl 0.1% formic acid for 
LC/ESI/MS/MS analysis run in the neutral loss mode for phosphopetides (Q-TOF Ultima 
API, Waters/Micromass, Manchester, UK; equipped with a capLC, Waters). 
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RESULTS 
 
Generation and characterization of monoclonal antibodies against PASKIN 
 
In order to determine the physiological sites of expression in vivo as well as the subcellular 
localization of mammalian PASKIN, monoclonal antibodies (mAbs) derived against PASKIN 
were generated. Therefore, a GST-PAS AB fusion protein was expressed in E. coli, purified 
and used for the immunization of mice. mABs were purified from hybridoma cell lines which 
reacted with GST-PAS AB but not GST alone. Two αPASKIN IgG2a mAbs, mAb2 and 
mAb6, recognized in vitro transcribed and translated (IVTT) human V5-PAS AB as well as 
His6-PASKIN by immunoblotting (Fig. 1A). However, none of the mAbs reacted with mouse 
PAS AB fragments, while αV5-tag antibodies readily detected the recombinant proteins (Fig. 
1A), demonstrating that these mAbs do not cross-react with mouse PASKIN. In human testis 
extracts both mAbs detected a single band that co-migrated with recombinant His6-PASKIN 
isolated from baculovirus-infected Sf9 cells (predicted MW: 146.4 kDa), suggesting that 
endogenous human PASKIN (predicted MW: 143.7 kDa) is either not or only slightly post-
translationally modified in the testis (shown for αPASKIN mAb6 in Fig. 1B). No 
corresponding band could be observed in mouse organs, including testis and brain (Fig. 1B). 
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Figure 1: Generation of two monoclonal antibodies (mAbs) specific for human PASKIN. (A) Mouse 
monoclonal αPASKIN antibodies mAb2 and mAb6 were purified and used for immunoblot detection of human 
and two different clones of the mouse V5-tagged PAS AB fragments produced by IVTT and full-length human 
His6-PASKIN expressed in Sf9 cells. The same blot was subsequently incubated with an anti-V5 tag antibody as 
control. (B) PASKIN wild-type or knock-out (KO) mouse and human tissue extracts were probed with mAb6 by 
immunoblotting. An extract from Sf9 cells expressing His6-PASKIN was included as positive control. The same 
blot was subsequently incubated with an anti-β-actin antibody as control. Note that the αPASKIN mAbs react 
with human but not mouse PASKIN.  
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PASKIN protein localization in germ cells of the testis 
 
We previously reported that the mouse Paskin gene is expressed in the testis at least 100-fold 
stronger than in every other organ tested [12]. As shown above, also immunoblotting revealed 
PASKIN protein only in the testis. Thus, αPASKIN mAb2 and mAb6 were used to analyze 
the PASKIN protein localization in human testis by immunohistochemistry. Signals for 
PASKIN were obtained in the outermost layer of cells in human seminiferous tubules, 
corresponding to the self-replicating spermatogonia, and in spermatocytes and round 
spermatids (Fig. 2A and C). At higher magnifications it became apparent that apart from some 
cytoplasmic staining PASKIN localized to the nuclei of spermatogonia and spermatocytes 
with a pattern that might match the nucleoli, at least in spermatogonia (Fig. 2B and D). In 
ejaculated human sperm cells, PASKIN localized mainly to the midpiece of the tail and was 
absent in the nucleus as determined by immunofluorescence (Fig. 2E and F). 
 
 
Figure 2: Subcellular localization of PASKIN in human testis and spermatozoa. Indirect immunohistochemistry 
of human testis (A to D) and indirect immunofluoresence of ejaculated human sperm cells (E, F). The primary 
αPASKIN antibodies are indicated; the secondary antibodies were coupled to HRP (A to D) or Texas red (E, F). 
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Cytoplasmic and nuclear localization of PASKIN in cultured cells 
 
Ectopically overexpressed V5-PASKIN had originally been reported to localize to the cytosol 
of transfected HEK293 cells [6]. Likewise, we detected exogenously overexpressed human 
His6-PASKIN exclusively in the cytoplasm of baculovirus-infected Sf9 insect cells by 
immunohistochemistry using αPASKIN mAb6 (Fig. 3A). However, by biochemical 
separation and immunoblotting, endogenous PASKIN had also been partially detected in the 
nuclear fraction of HeLa cells [6]. Moreover, a recent high-throughput screen identified 
PASKIN in nuclear extracts derived from HeLa cells [22]. Because PASKIN showed an 
unexpected nuclear pattern in human testis, we analyzed subcellular PASKIN localization in 
HeLa human cervical carcinoma cells as well as in NCCIT human male germ tumor cells. As 
shown by immunoblotting with αPASKIN mAb6, endogenous PASKIN could be detected in 
nuclear fractions derived from these cell lines in addition to the cytoplasmic fractions (Fig. 
3B). Over-expression markedly increased the portion of PASKIN in the nuclear fractions 
(Fig. 3C). Confocal microscopy of HeLa cells using αPASKIN mAb6 revealed a cytoplasmic 
as well as a nuclear PASKIN localization, not overlaping with areas that stained weakly with 
Hoechst33258 DNA stain (Fig. 3D). At present it is unclear whether the nuclear speckle-like 
PASKIN pattern in HeLa cells corresponds to the nucleolar-like pattern in spermatogonia. 
The cytoplasmic PASKIN staining overlaped neither with markers for the golgi apparatus 
(wheat germ agglutinin and concanavalin A) nor mitochondria (mitotracker) (data not shown). 
Taken together, these data show that PASKIN can localize to the nucleus as well as to the 
cytoplasm. 
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Figure 3: PASKIN localizes to the cytoplasm as well as to nuclear speckle-like structures in cultured HeLa cells. 
(A) Uninfected Sf9 cells, or Sf9 cells infected with human His6-PASKIN-baculovirus for 50 hours, were fixed, 
pelleted, embedded in paraffin, sectioned and analyzed by immunhistochemistry using αPASKIN mAb6. (B) 
Immunoblotting of cytoplasmic, nuclear or total cell extracts derived from HeLa cells using αPASKIN mAb6. 
Subsequent incubation with antibodies derived against the transcription factor Sp1 confirmed the identity of the 
extracts. (C) Immunoblotting of nuclear or total cell extracts derived from untransfected HeLa and NCCIT cells, 
or cells transfected with a V5-PASKIN expression vector, using αPASKIN mAb6. Subsequent detection of β-
actin served as control for equal loading and blotting (B, C). (D) Confocal indirect immunofluorescence 
microscopy of untransfected HeLa cells using αPASKIN mAb6. Nuclei were counterstained with Hoechst33258. 
The optical XZ and YZ planes are indicated on the sides of the XY picture to demonstrate the intranuclear 
localization of PASKIN. 
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The eukaryotic translation elongation factor eEF1A1 interacts with PASKIN 
 
In order to better understand the function of mammalian PASKIN, a yeast two-hybrid screen 
for novel proteins interacting with PASKIN was performed. eEF1A1 was identified as a prey 
when a region spanning the PAS A and B domains was used as bait. In order to confirm this 
interaction, mammalian two-hybrid experiments were performed in Hep3B human hepatoma 
cells co-transfected with Gal4 BD-PASKIN and VP16 AD-eEF1A1 fusion constructs. The 
activity of a co-transfected luciferase reporter gene construct containing five Gal4 DNA-
binding sites is greatly enhanced when the AD comes to lie in the vicinity of the BD. As 
shown in Fig. 4A, luciferase expression was significantly higher when the BD-PASKIN and 
AD-eEF1A1 fusion constructs were co-transfected compared with co-transfection of either 
the BD or the AD alone. Expression of the exogenous fusion proteins was confirmed by 
immunoblotting with anti-Gal4 or anti-VP16 antibodies (Fig. 4B). As shown in Fig. 4C, the 
KIN domain of PASKIN conferred even a stronger induction of luciferase activity than the 
full-length protein. Intriguingly, the two PAS domains did not stimulate luciferase expression 
but rather inhibited it when compared with the non-interacting negative control transfections 
(Fig. 4D). Thus, these results confirmed the interaction between the full-length PASKIN and 
eEF1A1 proteins, but showed that the PAS domains of PASKIN were inhibitory in the 
mammalian eEF1A1 interaction assay whereas they were activatory in the yeast eEF1A1 
interaction assay. 
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Figure 4: PASKIN:eEF1A1 interaction in Hep3B cells. Fusion proteins between VP16-AD and full-length 
PASKIN (A), or the KIN domain (C), or the PAS AB domain (D), together with Gal4-BD and eEF1A1 were co-
transfected into Hep3B cells together with a firefly luciferase reporter gene, containing Gal4 DNA-binding sites, 
and a renilla luciferase control vector. Firefly luciferase reporter gene activity was determined 24 hours later, 
corrected for the control renilla luciferase activity and normalized to the values obtained with a negative control 
transfection of a non-interacting fusion protein pair. B, Immunoblotting of transfected Hep3B cells to confirm 
expression of the fusion proteins. Anti-Gal4 mAb detected the BD and anti-VP16 mAb detected the AD. An 
unspecific band reacting with the anti-Gal4 mAb served to control for equal loading. Mean values ± SEM are 
shown of 7 (A, C) or 3 (D) independent experiments performed in duplicates. P values were obtained by paired t 
tests and considered significant if p < 0.05. 
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Mapping of the PASKIN domains interacting with eEF1A1 
 
The interaction between endogenous eEF1A1 and PASKIN was further confirmed by co-
immunoprecipitation. Because only very low amounts of endogenous PASKIN are expressed 
in HeLa cells (see Fig. 3B), c-myc-tagged PASKIN was transiently overexpressed and 
immunoprecipitated with αPASKIN mAb6. As shown in Fig. 5A, mAb6 but not an isotype-
matched control IgG co-precipitated endogenous eEF1A1. 
The PASKIN:eEF1A1 interaction was then characterized by GST pull-down experiments in 
vitro. Therefore, purified full-length His6-PASKIN was co-precipitated together with full-
length, N-terminal or the C-terminal GST-tagged eEF1A1 using glutathione sepharose (Fig. 
5B). Immunoblotting with αPASKIN mAb6 detected His6-PASKIN bound to full-length and 
C-terminal GST-eEF1A1 but not to N-terminal GST-eEF1A1 or GST alone (Fig. 5B, top), 
while αGST antibodies detected all proteins on the same blot (Fig. 5B, bottom).  
To map the PASKIN site(s) interacting with eEF1A1, fragments of PASKIN were transcribed 
and translated in wheat germ extracts and radioactively labelled by incorporation of 35S-Met. 
These fragments were tested for interaction with purified GST-eEF1A1 fusion proteins, or 
GST alone, by precipitation with glutathione sepharose. In this assay, the PAS A, PAS AB 
(Fig. 5C) as well as the KIN (Fig. 5D) domains interacted with eEF1A1, whereas the N-
terminal half of PAS A, PAS B, the N- and C-termini and the piece between the PAS and KIN 
domains (centerpiece) did not interact with eEF1A1.  
In conclusion, both the C-terminal part of the PAS A domain as well as the KIN domain 
independently interact with the C-terminal part of eEF1A1, providing an explanation why 
eEF1A1 could interact with the PAS domain of PASKIN in yeast and with the KIN domain of 
PASKIN in Hep3B cells. 
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Figure 5: PASKIN:eEF1A1 protein-protein interaction. (A) Co-immunoprecipitation of endogenous eEF1A1 
with c-myc-tagged PASKIN expressed in HeLa cells. αPASKIN mAb6 but not control antibodies co-
precipitated eEF1A1 as shown by immunoblotting. (B) Purified recombinant proteins derived from E. coli (GST 
alone or GST-tagged eEF1A1, full-length or the indicated fragments) or Sf9 insect cells (His6-PASKIN) were 
mixed, incubated and analyzed by GST pull-down with glutathione-sepharose followed by immunoblotting 
using αPASKIN and αGST mAbs. (C, D) Protein:protein interaction between radioactively labelled fragments 
of PASKIN produced by IVTT and purified recombinant GST-eEF1A1 fusion protein, or GST alone, were 
analyzed by GST pull-down with glutathione-sepharose followed by SDS-PAGE and phosphorimaging (upper 
panels in C and D). "Input" reflects fractions of the IVTT reactions before GST pull-down. The coomassie-
stained gels are shown in the lower panels of (C) and (D) to demonstrate equal pull-down efficiency. Note that 
the full-length GST-eEF1A1 fusion protein is barely visible in (C). 
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eEF1A1 is phosphorylated by PASKIN at Thr432 
 
We next determined whether eEF1A1 can be phosphorylated by PASKIN. Therefore, His6-
PASKIN was purified from baculovirus-infected Sf9 insect cells. As expected from published 
results [6], His6-PASKIN auto-phosphorylated in the presence of 33P-ATP, demonstrating that 
it was functionally active (Fig. 6A). PASKIN also phosphorylated full-length GST-eEF1A1 
and GST-eEF1A1247-462, whereas GST-eEF1A11-241 was phosphorylated to a clearly lower 
extent (Fig. 6A) and GST alone was not phosphorylated at all (data not shown). As shown by 
coomassie staining, all recombinant GST-tagged proteins were present in approx. equimolar 
concentrations (Fig. 6B), whereas the concentrations of the kinases were too low to be 
detected by this technique. 
To determine the phosphoacceptor site of eEF1A1, full-length GST-eEF1A1 was 
phosphorylated by His6-PASKIN, separated by SDS-PAGE and in-gel digested with trypsin. 
Separation of the fragments by liquid chromatography followed by electrospray ionization-
tandem mass spectrometry in the neutral loss mode for phosphopetides identified the C-
terminal peptide DMRQTVAVGVIK with Thr432 as the only phosphoacceptor site in this 
analysis (Fig. 6C).  
To confirm the role of Thr432 it was mutated to alanine by site-directed mutagenesis. As 
shown in Fig. 6A, phosphorylation of full-length GST-eEF1A1T432A by His6-PASKIN was 
almost completely abolished. However, while GST-eEF1A1247-462T432A also showed 
impaired phosphorylation by His6-PASKIN, some residual phosphorylation of this eEF1A1 
fragment was still detectable, suggesting that T432A is the major but not the only 
phosphoacceptor site on eEF1A1. 
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Figure 6: PASKIN auto-phosphorylation and eEF1A1 target-phosphorylation. (A) Purified recombinant GST-
eEF1A1 was in vitro phosphorylated by His6-PASKIN, separated by SDS-PAGE and detected by 
phosphorimaging. T432A mutants and fragments of eEF1A1 were included as indicated. (B) Corresponding 
coomassie-stained gel to indicate equimolar loading of phosphorylation target proteins. (C) Neutral loss 
measurement by LC/ESI/MS/MS of phospho-eEF1A1 following in-gel digestion. The mass difference of 48.989 
between the measurements of the peptide DMRQTVAVGVIK at low collision energy (upper trace) and at high 
collision energy (lower trace) shows the presence of a phosphorylation site in this peptide. Thr432 was identified 
as the main PASKIN-dependent phosphorylation site in eEF1A1. 
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PASKIN increases translation efficiency in a cell-free in vitro assay 
 
PASKIN-dependent phosphorylation of eEF1A1 suggests that PASKIN might influence 
translation efficiency. To test for this hypothesis, wild-type and kinase-inactive mutants of 
PASKIN were synthesized by IVTT in rabbit reticulocyte lysates (Fig. 7A). PASKIN was 
then tested for its effects on translation of a renilla luciferase cRNA in fresh rabbit 
reticulocyte lysates containing endogenous eEF1A1 (see Fig. 8A). While the empty IVTT 
expression vector, β-galactosidase, and kinase-inactive PASKIN T1161A and/or T1165A 
mutants [6] did not significantly alter protein synthesis, wild-type PASKIN increased renilla 
luciferase protein synthesis by 80% (Fig. 7B). 
 
Figure 7: PASKIN increases translation in a cell-free translation assay. (A) Wild-type PASKIN or the indicated 
kinase-inactive PASKIN mutants were produced by IVTT. Linearized expression vectors (agarose gel 
electrophoresis and ethidium bromide staining; top panel) were used to produce similar amounts of PASKIN 
protein (immunoblotting using αPASKIN mAb6; bottom panel). (B) Translation was assayed by adding 
fractions of these IVTT reactions to reticulocyte lysates containing renilla luciferase cRNA. Luciferase activities 
were normalized to the empty vector control and are shown as mean values ± SEM of n = 3 independent 
experiments. IVTT reactions using a lacZ vector expressing β-galactosidase served as negative controls. 
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Co-localization of PASKIN and eEF1A1 in the midpiece of the sperm tail 
 
Functional interaction between PASKIN and eEF1A1 requires a cellular co-localization. 
Thus, we next analyzed the subcellular localization of eEF1A1. Therefore, HeLa cells were 
analyzed by immunofluorescence using an αeEF1A1 mAb. Immunoblotting of IVTT 
reticulocyte extracts, containing or not containing an eEF1A1 expression vector, and of HeLa 
total cell extracts demonstrated the presence of eEF1A1 in HeLa cells and confirmed the 
specificity of the antibody (Fig. 8A). Indirect immunofluorescence with this antibody 
followed by an Alexa488-coupled secondary antibody localized eEF1A1 exclusively to the 
cytoplasm (Fig. 8B). A similar cytoplasmic localization was observed in germ cells of the 
human testis by immunohistochemistry (Fig. 8C). Interestingly, by indirect 
immunofluorescence using a Texas red-coupled secondary antibody eEF1A1 was also 
detected in the tail of ejaculated human sperm (Fig. 8D). Confocal immunofluorescence 
microscopy revealed a very similar pattern of eEF1A1 and PASKIN, suggesting co-
localization of the two proteins in the midpiece of the sperm tail (Fig. 8E). 
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Figure 8: eEF1A1 and PASKIN co-localization in HeLa and sperm cells. (A) Immunoblot analysis of eEF1A1 
in unprimed reticulocyte lysates, or following IVTT of an eEF1A1 expression vector, and in untransfected HeLa 
cells, demonstrating the specificity of the αeEF1A1 mAb. (B) Confocal indirect immunofluorescence 
microscopy of untransfected HeLa cells using αeEF1A1 primary and Alexa488-coupled secondary antibodies. 
(C) Immunohistochemistry of human testis using αeEF1A1 mAb (red). Note that both in HeLa (B) as well as in 
testis (C), eEF1A1 localizes to the cytoplasm, suggesting that this is the main site of interaction with PASKIN in 
these cells. (D) Indirect eEF1A1 immunofluorescence microscopy of human ejaculated sperm using αeEF1A1 
primary and Texas red-coupled secondary antibodies. E, Confocal indirect immunofluorescence microscopy of 
the midpiece of the human sperm tail using αeEF1A1 or αPASKIN mAb6 primary and Texas red-coupled 
secondary antibodies. Nuclei were counterstained with DAPI (B) or Hoechst33258 (D, E). 
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DISCUSSION 
 
We previously identified PASKIN as a gene that is ubiquitously expressed at low abundance 
in most mouse organs analyzed. In contrast, much higher mRNA levels were found in the 
testis [5,12]. Presumably, these low levels in somatic tissues can further be induced by 
changing environmental conditions, as suggested by the recent demonstration that high 
glucose induces PASKIN in pancreatic β-cells [10]. Of note, in a large-scale characterization 
of nuclear phosphoproteins, a PASKIN-derived phosphopeptide (Ser116) was identified in 
HeLa cells, suggesting a potentially regulatable function for PASKIN [22]. Thus, HeLa 
appeared to be a valuable tool to identify PASKIN downstream targets in non-germline cells, 
and we identified the translation elongation factor eEF1A1 as a novel PASKIN interaction 
partner by yeast two-hybrid screening.  
We further demonstrated that the C-terminal part of eEF1A1 interacts with both the PAS A 
and KIN domains of PASKIN as schematically summarized in Fig. 9. 
 
 
Figure 9: Scheme of the PASKIN:eEF1A1 interaction. Results from Figs. 4 and 5 are summarized on the right 
part of the picture. The eEF1A1 phosphopeptide identified following PASKIN-dependent phosphorylation is 
indicated. Y2H, yeast two-hybrid; M2H, mammalian two-hybrid; coIP, co-immunoprecipitation. 
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Human eEF1A1 is phosphorylated by PASKIN at Thr432, suggesting that PASKIN regulates 
eEF1A1 function. Several other kinases are known to phosphorylate eEF1A1, including 
PKCδ, Rho-associated kinase, and S6 kinase [23-25]. Interestingly, PKCδ has been shown 
previously to phosphorylate the corresponding Thr431 PASKIN target site in mouse eEF1A1 
[23], and we found PKCδ-dependent human eEF1A1 phosphorylation at Thr432 (data not 
shown). Up to date the functional consequences of this phosphorylation remain unknown. 
Insulin stimulation of protein synthesis involves S6 kinase-dependent eEF1A1 
phosphorylation [25], and here we could demonstrate that PASKIN increases protein 
translation in a cell-free translation assay. Thus, PASKIN-dependent phosphorylation of 
eEF1A1 might link energy metabolism with protein translation in mammalian cells as it has 
been demonstrated previously for yeast [8]. However, the major site of PASKIN expression in 
vivo is the testis. Because no corresponding cell culture model is available, at present we can 
only speculate on a role for PASKIN in protein translation in male germ cells. 
In addition to protein translation, PASKIN-dependent eEF1A1 phosphorylation might also 
have completely different consequences. In fact, eEF1A1 displays a multitude of functions 
unrelated to protein synthesis, including cytoskeletal organization, signal transduction, RNA 
synthesis, proteasomal degradation of damaged proteins, apoptosis and activation of the heat-
shock transcription factor; eEF1A1 hence is involved in major diseases such as diabetes and 
cancer [15,17,26]. We thus reasoned that the identification of the subcellular compartments 
which show co-localization of eEF1A1 and PASKIN might give further hints to the 
physiological functions of PASKIN-dependent eEF1A1 phosphorylation. In baculovirus-
infected insect cells, we found PASKIN exclusively in the cytoplasm, consistent with a 
previous report on transiently transfected HEK293 cells [6]. Cytoplasmic localization of 
endogenous PASKIN was also found in HeLa cells, suggesting a role for the 
PASKIN:eEF1A1 interaction in this compartment. However, in order to study the major 
physiological site of PASKIN expression, the testis, it was necessary to generate specific 
αPASKIN antibodies. Unexpectedly, endogenous PASKIN showed an apparently nucleolar 
pattern in spermatogonia and a more speckled nuclear pattern in spermatocytes and in HeLa 
cells in addition to the cytoplasmic localization. A previously not recognized phosphorylation 
site of PASKIN (Ser116) has been identified in nuclear extracts derived from HeLa cells [22]. 
It is currently unknown whether phosphorylation of PASKIN Ser116 affects PASKIN 
subcellular localization, PASKIN kinase activity, or both. 
Although also eEF1A1 has been reported to localize to the nucleus under certain 
circumstances [15], we detected endogenous eEF1A1 exclusively in the cytoplasm of HeLa  
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cells and germ cells of human testis. However, there was a complete, and thus far not 
recognized, overlap in PASKIN and eEF1A1 expression and localization in mature human 
spermatozoa. Because these cells ceased protein translation, a translation-unrelated function 
of PASKIN-dependent eEF1A1 phosphorylation appears to be likely. The midpiece of the 
sperm tail is a highly organized structure comprising cytoskeletal components, the 
mitochondria, and most of the remaining cytoplasmic liquid which contains several testis-
specific isoforms of glycolytic enzymes as well as of the transcription factor HIF-1α, another 
PAS domain protein [13,27,28]. Thus, this site is involved in the response to external stimuli 
by regulation of energy flux, heat-stress response and apoptosis, features that would be 
consistent with the known functions of PASKIN and eEF1A1. Future experiments will be 
required to identify the external stimuli affecting these features. 
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ABSTRACT 
 
The PAS domain serine/threonine kinase PASKIN, or PAS kinase, links energy flux and 
protein synthesis in yeast and regulates glycogen synthesis and protein translation in 
mammals. According to the current model, binding of a putative ligand to the PAS 
domain disinhibits the kinase domain, leading to PASKIN autophosphorylation and full 
kinase activity. Synthetic ligands have been reported to be bound by PASKIN. However, 
it was unknown whether endogenous ligands exist and how they affect PASKIN kinase 
activity. Here, we identified phospholipids as potent stimulators of PASKIN 
autophosphorylation. Immobilized phospholipids dose-dependently bound purified 
PASKIN protein. Phospholipase C but not D abrogated phospholipid interactions with 
PASKIN, suggesting that phosphatidic acid is the minimal moiety binding to PASKIN. 
Indeed, phosphatidic acid was sufficient to fully activate PASKIN autophosphorylation. 
Interestingly, while phospholipids stimulated PASKIN autophosphorylation, 
phosphorylation of the eukaryotic translation elongation factor eEF1A1, a recently 
identified PASKIN target protein, was inhibited. 
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INTRODUCTION 
 
In lower organisms, the PAS (Per-Arnt-Sim) domain is often found in environmental protein 
sensors involved in the perception of light intensity, oxygen partial pressure, redox potentials, 
voltage and certain ligands [1]. In mammals, the PAS domain is mainly found as a 
heterodimerization interface of transcription factors involved in dioxin signalling, the 
circadian clock and oxygen sensing [2-4]. We and others previously identified a novel 
mammalian PAS protein, alternatively called PASKIN [5] or PAS kinase [6]. PASKIN 
contains two PAS domains (PAS A and PAS B) and a serine/threonine kinase domain which 
might be regulated in cis by binding of so far unknown ligands to the PAS domain [7]. 
PASKIN shows a striking structural similarity to the bacterial oxygen sensor FixL that 
contains an oxygen-binding heme group within its PAS domain [5]. Following derepression 
by ligand binding, autophosphorylation in trans results in the "switch-on" of the kinase 
domain of FixL and probably of PASKIN as well [6]. PSK1 and PSK2, the budding yeast 
homologs of PASKIN, phosphorylate three translation factors and two enzymes involved in 
the regulation of glycogen and trehalose synthesis, thereby coordinately controlling 
translation and sugar flux [8]. In mammals, PASKIN-dependent phosphorylation inhibits the 
activity of glycogen synthase [9]. PASKIN has also been suggested to be required for 
glucose-dependent transcriptional induction of preproinsulin gene expression, which might be 
related to PASKIN-dependent regulation of the nuclear import of pancreatic duodenal 
homeobox-1 transcription factor PDX-1 [10,11]. However, by using normally fed PASKIN-
deficient knock-out mice, we could not observe any PASKIN-dependent difference in insulin 
gene expression or in glucose tolerance [12] [13].  
 We previously found that the eukaryotic translational elongation factor eEF1A1 is 
phosphorylated by PASKIN at threonine 432, probably leading to increased translation 
elongation [14]. Because eEF1A1 is also phosphorylated by PKCδ, we compared the features 
of the two kinases, in particular their activation by lipids. As expected, PKCδ kinase activity 
could be induced by a mixture of phosphatidylserine and diacylglycerol. Surprisingly, 
PASKIN kinase activity could also be stimulated by phospholipids but not by diacylglycerol.  
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MATERIALS AND METHODS 
 
Plasmids 
 
All cloning work was carried out using Gateway technology (Invitrogen, Basel, Switzerland). 
Human PASKIN cDNA (kindly provided by J. Rutter, Salt Lake City, UT, USA) was cloned 
into pENTR (Invitrogen) as described elsewhere [14]. To generate expression vectors for 
fusion proteins, ENTRy vectors were recombined in vitro with DESTination vectors using LR 
Clonase recombination enzyme mix (Invitrogen). pDEST15, pDEST17 and pMAL were used 
to generate bacterial expression vectors for glutatione-S-transferase (GST)-, His6- and 
maltose-binding protein (MBP)-tagged fusion proteins, respectively. pDEST10 and pDEST20 
were used to generate expression vectors for His6- and GST-tagged fusion proteins, 
respectively, in the baculovirus/Sf9 insect cell system (Invitrogen). pcDNA3.1/nV5-DEST 
was used to express N-terminal V5-tagged proteins in mammalian cells or in rabbit 
reticulocyte lysates.  
 
 
PASKIN expression and purification 
 
His6-PASKIN was purified from baculovirus-infected Sf9 insect cells using passive lysis 
buffer (Promega, Madison, WI) and Ni2+-NTA agarose (Qiagen, Basel, Switzerland). His6-
PASKIN purity was checked by SDS-PAGE followed by coomassie or SYPRO ruby staining 
(Molecular Probes/Invitrogen), or by immunoblotting using monoclonal anti-PASKIN 
antibody mAb6 [14]. PASKIN purity was quantified by fluorescence imaging using a 
sensitive CCD camera (FluorChem8900, AlphaInnotech, Witec, Littau, Switzerland). 
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Kinase assays 
 
His6-PASKIN or PKCδ (Invitrogen) was incubated with or without 2 μg bacterially expressed 
and purified GST-tagged or MBP-tagged target proteins in kinase buffer (25 mM Tris-HCl 
pH 7.5, 10 mM MgCl2, 1 mM DTT) for 20 minutes in the presence of 3 μCi (γ-33P)ATP 
(Hartmann Analytic, Braunschweig, Germany). Proteins were separated by SDS-PAGE and 
analyzed by phosphorimaging of the dried gels (Molecular Imager FX, BioRad, Reinach, 
Switzerland). Lipids were dissolved in CHCl3, aliquotted in test tubes and the CHCl3 
evaporated under a stream of nitrogen. Lipids were then resuspended in kinase assay master 
mixes by thoroughly vortexing. 
 
 
Lipid binding assays 
 
Interactions between PASKIN and lipids were measured by an ELISA-based assay described 
previously [15]. Briefly, 96-well plates (Sarstedt, Nümbrecht, Germany) were coated 
overnight with phospholipids dissolved in methanol, followed by blocking with 3% BSA in 
PBS for 1 hour. Purified His6-PASKIN (100 ng) was diluted in kinase buffer and allowed to 
bind for 1 hour at 30°C. After three washing steps (0.3% Tween-20 in PBS), bound PASKIN 
was detected by anti-PASKIN mAb6, followed by secondary goat anti-mouse HRP-
conjugated antibodies (Pierce, Perbio, Lausanne, Switzerland) using the 3,3',5,5'-
tetramethylbenzidine substrate kit (Pierce). The peroxidase reaction was stopped by adding 
H2SO4 (1 M final concentration) and absorbance was determined at 450 nm in a microplate 
reader. For phospholipase (PL) experiments, phospholipid-coated 96-well plates were treated 
with 0.2 units PLC or PLD (Sigma), diluted in reaction buffer (120 mM CaCl2, 300 mM 
sodium acetate pH 5.6) for 1 hour at room temperature.  
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RESULTS 
 
Autophosphorylation of recombinant PASKIN is activated by lipids  
 
Functionally active His6-tagged PASKIN was affinity-purified from baculovirus-infected Sf9 
insect cells (Fig. 1A). Following staining with a fluorescent dye, quantification of the 146.4 
kDa band by fluorimaging of SDS-PAGE gels revealed a purity of at least 80% (Fig. 1B). By 
immunoblotting, many of the smaller bands represent degradation products as they reacted 
with a monoclonal anti-PASKIN antibody, suggesting an even higher proportion of PASKIN 
in this preparation (Fig. 1C).  
As reported previously [6], recombinant His6-PASKIN autophosphorylated in the prescence 
of radioactively labelled ATP (Fig. 1D) and a T1165A mutant form of PASKIN completely 
lacked autophosphorylation activity (data not shown). To investigate whether PASKIN 
autophosphorylation within its kinase domain (Thr1161 and Thr1165) occurs in cis or in 
trans, the PAS domain (GST-PAS AB) or the kinase domain (MBP-KIN) of PASKIN, or the 
GST or MBP tags alone, were added to the PASKIN kinase reactions. As expected, the PAS 
domain or the tags alone were neither phosphorylated by PASKIN nor affected PASKIN 
autophosphorylation (Fig. 1D). However, rather than being phosphorylated by PASKIN, the 
presence of the PASKIN kinase domain inhibited PASKIN autophosphorylation (Fig. 1D).  
PASKIN and PKCδ are both known to autophosphorylate [6,16], as well as to phosphorylate 
the eukaryotic translation elongation factor eEF1A1 [14]. Because PKCδ kinase activity is 
known to be stimulated by diacylglycerol (DAG) and phosphatidylserine (PS) [17], we 
wondered whether additional similarities exist between PASKIN and PKCδ. Interestingly, a 
mixture of PS and DAG (used in the form of dioctanoylglycerol, DOG) not only enhanced 
PKCδ but also PASKIN autophosphorylation (Fig. 1E).  
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Figure 1: Purification and autophosphorylation of PASKIN. A, Coomassie-stained SDS-PAGE gel of Sf9 cell 
extracts infected with baculovirus containing His6-PASKIN expression vectors. PASKIN was purified from 
these extracts by Ni2+-NTA agarose affinity chromatography as indicated. B, PASKIN was separated by SDS-
PAGE and stained with a fluorescent dye to determine its purity. C, Immunoblotting of the fractions shown in A, 
using an anti-PASKIN monoclonal antibody. D, PASKIN autophosphorylation in the presence or absence of 
GST, GST-PAS AB, MBP, or MBP-KIN. E, A DOG/PS lipid mixture stimulates PKCδ as well as PASKIN 
autophosporylation. D and E, Kinase reaction mixtures were separated by SDS-PAGE and the radioactive bands 
of the dried gels were detected by phosphorimaging.  
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Phospholipids but not DAG stimulate PASKIN autophosphorylation 
 
In order to systematically analyze the lipid activation of PASKIN, all major phospholipids 
were compared for their effects on PASKIN and PKCδ autophosphorylation. As shown in 
Fig. 2, all tested phospholipids but not DOG alone increased PASKIN autophosphorylation. 
In contrast, PKCδ autophosphorylation was induced by DOG alone, to some extent also by PS 
or phosphatidylcholine (PC), but all other phospholipids had only marginal effects on PKCδ. 
As known before, a mixture between DOG and PS was required to maximally induce PKCδ 
activity. However, combining DOG with phospholipids did not further induce PASKIN (data 
not shown).  
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Figure 2: PASKIN autophosphorylation is stimulated by various phospholipids. PASKIN or PKCδ 
autophosphorylation was stimulated with increasing amounts of the indicated (phospho-)lipids and quantified by 
phosphorimaging after SDS-PAGE. 
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PASKIN binds a distinct set of phospholipids 
  
To characterize phospholipid binding by PASKIN, an ELISA-based assay was applied. 
Therefore, 96-well plates were coated with increasing amounts of a variety of phospholipids 
and remaining binding sites were blocked with BSA. Purified recombinant PASKIN was 
allowed to bind to the phospholipids and the amount of bound PASKIN was determined by a 
monoclonal anti-PASKIN antibody. As shown in Fig. 3A, PASKIN bound to the 
phospholipids phosphatidylethanolamine (PE), PS and phosphatidic acid (PA), but not to 
DOG or to the other phospholipids (PC; phosphatidylinositol, PI; sphingomyelin, S) tested. 
This was somewhat unexpected since PASKIN autophosphorylation was also induced by 
other phospholipids. However, when higher amounts of PASKIN were used in this assay, 
binding to PC could also be demonstrated (Fig. 3B), suggesting different PASKIN affinities 
for the various phospholipids.  
The finding that PA but not DOG strongly bound PASKIN suggested that PLD might target 
PASKIN by converting phospholipids into PA. To directly demonstrate this assumption, 
constant amounts of bound PC (1 μg) were treated with PLD or PLC followed by binding to 
increasing amounts of PASKIN. As shown in Fig. 3B, PLD but not PLC converted PC into a 
lipid binding PASKIN efficiently. On the other hand, the lipid affinity of a constant amount of 
PASKIN (100 ng) was enhanced when increasing amounts of PC were treated with PLD, but 
not with PLC, (Fig. 3C). In summary, PLD-dependent PA production, but not PLC-dependent 
DOG production, increased the strength of the interaction between PASKIN and 
phospholipids. We could not detect higher PASKIN affinities for any of the phospholipids 
tested than for the PA backbone alone.  
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Figure 3: PASKIN-phospholipid interaction. A, 96-Well plates were coated with increasing amounts of the 
indicated (phospho-)lipids followed by incubation with purified PASKIN (100 ng). Following vigorous washing, 
PASKIN was detected with a monoclonal anti-PASKIN antibody followed by a secondary HRP-coupled 
antibody. B and C, PLD but not PLC converts PC from a low affinity to a high affinity PASKIN ligand. 96-Well 
plates were coated with constant (1 μg, B) or increasing (C) amounts of PC, followed by treatment with PLD or 
PLC. Binding of increasing (B) or constant (100 ng) (C) amounts of PASKIN was quantified as for A. B and C, 
Untreated wells coated with equal amounts of PC or PA served as controls. Shown are mean values ± SD of a 
representative experiment performed in triplicates.  
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Phospholipid stimulation of eEF1A1 phosphorylation by PASKIN 
 
Because autophosphorylation of PASKIN has been suggested to increase its kinase activity 
[6], we next analyzed whether phospholipid-stimulated PASKIN autophosphorylation also 
leads to increased target protein phosphorylation. We previously demonstrated that eEF1A1 
Thr432 is phosphorylated by PASKIN [14].  
Unexpectedly, while PA induced PASKIN autophosphorylation it reproducibly inhibited 
eEF1A1 target protein phosphorylation (Fig. 4). This was not observed with PS and PE whose 
stimulatory activity on PASKIN autophosphorylation was slightly inhibited by the presence 
of eEF1A1.  
 
Figure 4: Effects of phosphoplipids on PASKIN-dependent eEF1A1 phosphorylation. PASKIN was stimulated 
with the indicated (phospho-)lipids in the absence (left panel) or presence (right panel) of recombinant GST-
tagged eEF1A1. Following SDS-PAGE, phosphorylated proteins were detected by phosphorimaging. 
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DISCUSSION 
 
Based on the known function of the PASKIN-related FixL oxygen sensor in bacteria, the role 
of the PASKIN orthologs in yeast, and the structural and functional studies of PASKIN in 
mammals, a ligand-dependent disinhibition of the kinase activity of PASKIN seems to be an 
attractive hypothesis. However, only synthetic but no endogenous PASKIN ligands have been 
identified so far and the functional implications of the binding of these ligands have not been 
assessed experimentally [7]. Having identified a target protein phosphorylated by both 
PASKIN and PKCδ [14], we wondered whether other similarities between PASKIN and 
PKCδ might exist. Indeed, phospholipids were identified as PASKIN ligands and efficient 
stimulators of PASKIN kinase activity. As expected from the different domain composition, 
our data revealed similarities but also clear differences between PASKIN and PKCδ 
stimulation by phospholipids. Apparently, the presence of a charged phosphate moiety is 
required for stimulation of PASKIN kinase activity, and PLD, but not PLC, can convert 
phospholipids from low into high-affinity PASKIN ligands. These data suggest that receptor-
mediated intracellular signalling via PLD might regulate PASKIN function. However, up to 
date no extracellular ligands for cell surface receptors are known which would affect PASKIN 
function in vivo. 
It has been suggested that glucose stimulates PASKIN expression and activity by an unknown 
mechanism. Activated PASKIN is thought to stimulate PDX-1 expression and nuclear import, 
leading to increased preproinsulin gene expression in pancreatic β-cells [10,11]. However, 
PASKIN phosphorylates PDX-1 Thr152 in vitro which apparently inhibits PDX-1 nuclear 
uptake [11]. Thus, there appears to be a contradiction between induced PDX-1 Thr152 
phosphorylation by activated PASKIN and increased PASKIN-dependent nuclear PDX-1 
function. Based on our findings, a model might be plausible which resolves this contradiction: 
glucose might stimulate an intracellular signalling pathway that activates PLD, leading to 
increased PA formation. PA in turn stimulates PASKIN autophosphorylation but inhibits 
PASKIN target phosphorylation like we found for eEF1A1. Thus, activated PASKIN might 
actually show decreased PDX-1 Thr-152 phosphorylation, allowing PDX-1 nuclear 
translocation. Indeed, it is known that glucose stimulates PLD activity and inhibition of PLD-
dependent PA formation with butan-1-ol blocks PLD-dependent insulin secretion [18]. While 
we were unable to confirm a glucose-dependent increase in PASKIN mRNA levels [13], there 
might still be nutrient conditions that regulate PASKIN activity rather than PASKIN mRNA 
or protein levels. We hence aim to establish methods to measure changes in intracellular  
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PASKIN autophosphorylation and kinase activity following activation of the PLD signalling 
pathway. 
Due to the concentration-dependent induction of PASKIN kinase activity, it has previously 
been suggested that PASKIN autophosphorylation within its kinase domain occurs in trans 
[6]. To directly assess how phospholipids lead to an induction of PASKIN 
autophosphorylation, we added PAS or KIN fragments of PASKIN to kinase assays 
containing the full-length PASKIN protein. However, neither the PAS nor the KIN fragments 
were phosphorylated by PASKIN. If anything, the presence of the KIN fragment inhibited 
PASKIN autophosphorylation. These data suggest that the entire protein is required to serve 
as a target for autophosphorylation, including the PAS domain that is known from several 
transcription factors to serve as protein-protein interaction domain and hence might also be 
required for PASKIN-PASKIN interaction to allow trans-autophosphorylation.  
Currently, we do not know how phospholipids activate PASKIN autophosphorylation. PA and 
PS are bound by cysteine-rich motifs in PKC and Raf [15,19,20]. Binding of PA results in 
Raf-1 translocation to the inner surface of the plasma membrane, interaction with Ras and 
activation of MAP kinases [15,21,22]. However, whereas the kinase domain of PASKIN 
showed a high similarity to the kinase domains of PKC and Raf, PASKIN does not have any 
cysteine-rich sequences, suggesting a different PA binding site. Moreover, PASKIN 
immunofluorescence studies did not reveal any subcellular relocalization following treatment 
with PA, LPA or phorbol ester (data not shown). 
With the identification of endogenous small molecule activators of PASKIN, we obtained the 
first hints on the upstream regulators of PASKIN activity and it will be a major future 
challenge to identify the signalling pathways and PASKIN-dependent downstream processes 
that are affected by these regulators. 
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ABSTRACT 
 
PASKIN is a PAS domain AMP-related serine/threonine kinase highly expressed in the 
testis. Male PASKIN knock-out mice are normally fertile. Thus, the function of PASKIN 
in the testis probably becomes only apparent under stress conditions, like it is known 
from its yeast orthologs. Following disruption of normal testis homeostasis, PASKIN 
might sense the altered concentration of a (unknown) metabolic ligand, which triggers 
the downstream phosphorylation of (unknown) target proteins. We reasoned that the 
identification of such PASKIN interaction proteins will help to elucidate the function of 
PASKIN during spermatogenesis. Initially, a HeLa cell-derived cDNA library was 
screened with the Matchmaker yeast two-hybrid system using the PAS fragment of 
PASKIN as bait for protein-protein interaction. A translation factor was identified and 
its interaction with PASKIN could be confirmed by in vitro assays. Further screening of 
a human testis cDNA library using the kinase domain of PASKIN as bait revealed the 
interaction with proteins involved in DNA repair and signal transduction. Thus, yeast-
two hybrid technology might provide useful informations on PASKIN function despite 
the lack of a haploid cell culture model which would be required to study the function of 
endogenous PASKIN in vitro. 
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INTRODUCTION 
 
PAS (Per-Arnt-Sim) proteins are known from all three kingdoms of life and represent protein 
sensors involved in the perception of light intensity, oxygen partial pressure, redox potentials, 
voltage and certain ligands [1-3]. The mammalian PAS domain-containing proteins can also 
serve as heterodimerization interfaces of transcription factors involved in the xenobiotic 
response, adaptation to hypoxia and circadian rhythm generation [4-6].  
By database searches using the PAS sequence as bait [7], we and other labs identified a novel 
mammalian PAS protein termed PASKIN [8] or PASK [9]. PASKIN contains two PAS 
domains showing a high structural similarity to the oxygen sensor protein FixL of Rhizobium 
species, and a serine/threonine kinase domain which is related to the AMP-kinases. As known 
from FixL, PASKIN represses its kinase activity in cis. Upon ligand-binding to the PAS 
domain of PASKIN, activation of the kinase domain takes place in trans, resulting in the 
autophosphorylation of the kinase domain [9]. Ligand binding as well as mutation of the PAS 
A domain results in the activation of the kinase domain. Synthetic ligands are identified and 
show a structural similarity to dioxin, known to bind to the PAS domain of the aryl 
hydrocarbon receptor [10]. However, an endogenous ligand for PASKIN activation has not 
been identified so far.  
To elucidate the function of PASKIN, our lab generated PASKIN deficient knock-out mice. 
PASKIN is highly upregulated in the testis during the post-meiotic stage of spermatogenesis. 
PASKIN mRNA expression is remarkably higher in the testis compared to other tissues such 
as lung, liver and kidney. However, neither male fertility nor sperm production or motility 
was affected in PASKIN knock-out mice [11]. 
The first insights into target identification of PASKIN were described for the yeast PASKIN 
homologs PSK1 and PSK2. Under stress conditions, the psk1 psk2 double-mutant strain 
shows a decreased growth at elevated temperature (39°C) and galactose supply. PSK1 and 
PSK2 phosphorylate three translation factors (Caf20, Tif11 and Sro9) and two enzymes 
involved in glycogen and trehalose synthesis (Ugp1, Gsy2), coordinately controlling 
translation and carbohydrate flux [12]. Recently, it was shown that the mammalian glycogen 
synthase interacts with the midregion of human PASKIN and is phosphorylated at Ser-640 
[13]. In a yeast two-hybrid screen for novel interacting proteins of PASKIN, we recently 
identified the multifunctional eukaryotic translation elongation factor eEF1A1 using a HeLa 
cDNA library. Interaction studies showed that the PAS A and the kinase domain of PASKIN 
interact with the C-terminus of eEF1A1. We could also demonstrate that eEF1A1 is mainly 
but not exclusively phosphorylated at Thr 431, probably leading to increased translation 
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elongation. Surprisingly, these two proteins showed a similar localization in the midpiece of 
the sperm tail, suggesting that phosphorylation of eEF1A1 by PASKIN might regulate 
translational elongation in sperm cells [14].  
To verify the functional role of PASKIN in the testis, we repeated the yeast two-hybrid 
screening with a human testis cDNA library and the kinase domain of PASKIN as bait. One 
of the three identified putative interaction partners is the multifunctional protein Ku70 that is 
involved in a wide range of cellular processes such as apoptosis, DNA repair or transcription 
[15]. We could show that compared to the two other interactors, the inhibitor of activated 
STAT and the testis zinc finger protein, only Ku70 interacts with the kinase domain of 
PASKIN using in vitro GST pull-down assays. However, no phosphorylation by PASKIN 
was observed for Ku70.  
 
 
MATERIALS AND METHODS 
 
Yeast two-hybrid library and bait construction 
 
A human testis-derived cDNA library was screened using the kinase domain of human 
PASKIN as bait according to the instructions provided by the manufacturer (Matchmaker; 
Clontech-Takara, Saint-Germain-en-Laye, France). Therefore, the full-length human PASKIN 
cDNA clone pDKFZp434O1522 [8] was digested with NcoI and SmaI and the cDNA 
fragment inserted into the NcoI-SmaI sites of the pLexA vector (Dualsystems, Zürich, 
Switzerland). Subsequently, the N-terminal part was deleted by SacII-StuI digestion and re-
ligated to obtain pLexA-KIN.  
 
 
Yeast two-hybrid screening 
 
DSY-1 competent yeast cells were transfected with the bait vector pLexA-KIN. DSY/pLexA-
KIN yeast cells were transfected with 50 μg of library cDNA and co-transformants were 
selected for resistance to medium lacking tryptophan, leucine and histidine. To eliminate 
background growth, 2.5 mM 3-amino-1,2,4-triazole (3-AT) a competitive inhibitor of the 
HIS3 gene product, was used. Positive clones were further analyzed for growth on drop-out 
medium containing different 3-AT concentrations (0-50 mM), and for β-galactosidase activity 
to characterize the interaction intensity. When yeast cell passed this selection process, the 
AD-containing plasmid was isolated. Therefore, the yeast cells were centrifuged and lysed in 
500 μl sorbitol buffer (3 M sorbitol, 0.5 mM EDTA, β-mecaptoethanol, 733 units/mg  
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lyticase) at 30°C for 30 min. The plasmid DNA was precipitated with 3 M potassium acetate 
and isopropanol as described by the manufacturer (Qiagen, Basel, Switzerland). Purified AD-
containing plasmids were used for transformation of XL1-blue MRF’ competent bacteria, 
which were selected on LB-ampicillin agar plates. Purified bacterial plasmid DNA was 
sequenced by Microsynth (Balgach, Switzerland). The sequences were analyzed and 
identified using BLAST (http://www.ncbi.nlm.nih.gov/BLAST/) and protein 
(http://au.expasy.org/) search engines.  
 
 
Plasmids 
 
All cloning work for bacterial and insect cell expression was carried out using Gateway 
technology (Invitrogen, Basel, Switzerland). Human PASKIN cDNA (kindly provided by J. 
Rutter, Salt Lake City, UT, USA) was cloned into pENTR4 (Invitrogen) as described 
elsewhere [14]. To generate expression vectors for fusion proteins, ENTRy vectors were 
recombined in vitro with DESTination vectors using LR Clonase recombination enzyme mix 
(Invitrogen). pDEST15 and pDEST17 were used to generate bacterial expression vectors for 
glutatione-S-transferase (GST)- and His6-tagged fusion proteins. pDEST10 was used to 
generate expression vectors for His6-tagged PASKIN fusion protein in the baculovirus/Sf9 
insect cell system (Invitrogen).  
 
 
PASKIN expression and purification 
 
His6-PASKIN was purified from baculovirus-infected Sf9 insect cells using passive lysis 
buffer (Promega, Madison, WI) and Ni2+-NTA agarose (Qiagen). His6-PASKIN purity was 
checked by SDS-PAGE followed by coomassie or SYPRO ruby staining (Molecular 
Probes/Invitrogen), or by immunoblotting using monoclonal anti-PASKIN antibody mAb6 
[14]. PASKIN purity was quantified by fluorescence imaging of the SYPRO ruby stained gels 
using a sensitive CCD camera (FluorChem8900, AlphaInnotech, Witec, Littau, Switzerland). 
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GST pull-down 
 
Pull-down experiments were performed by mixing either purified proteins or 20 µl wheat 
germ IVTT (Promega, Madison, USA) reactions with 10 µg purified GST-tagged proteins or 
GST alone bound to glutathione sepharose beads. After 30 minutes incubation at room 
temperature in bead binding buffer (50 mM Tris-HCl pH 8.0, 1 mM EDTA, 1 mM DTT, 150 
mM NaCl, 0.01% NP40), beads were washed 3 times with washing buffer (50 mM Tris-HCl 
pH 8.0, 1 mM EDTA, 1 mM DTT, 150 mM NaCl, 0.5% NP40), boiled in sample buffer (40 
mM Tris-HCl pH 6.8, 1% SDS, 50 mM β-mercaptoethanol) for 5 minutes and the proteins 
separated by SDS-PAGE. Gels were stained with coomassie blue, dried and radioactively 
labelled proteins detected by phosphorimaging (Molecular Imager FX, BioRad, Reinach, 
Switzerland). 
 
Kinase assays 
 
100 ng His6-PASKIN or 90 ng PKCδ (Invitrogen) were incubated with or without 2 μg 
bacterially expressed and purified GST-tagged proteins in kinase buffer (25 mM Tris-HCl pH 
7.5, 10 mM MgCl2, 1 mM DTT) for 2 hours at 30°C in the presence of 3 μCi (γ-33P)ATP 
(Hartmann Analytic, Braunschweig, Germany). Proteins were separated by SDS-PAGE and 
analyzed by phosphorimaging of the dried gels. Lipids were dissolved in CHCl3, aliquoted in 
test tubes and the CHCl3 evaporated under a stream of nitrogen. Lipids were then resuspended 
in kinase assay master mixes by thoroughly vortexing. 
 
 
RESULTS 
 
Identification of the novel PASKIN interactors Ku70, iSTAT and tZFP by yeast two-
hybrid screening 
 
A yeast two-hybrid screen with a total number of 7.9×104 colonies was performed with the 
kinase domain of PASKIN as bait and a human testis cDNA library. Three of 73 preys 
interacted with the pLexA-KIN fusion protein after retransformation and showed the correct 
open reading frame by sequencing. The other 70 initial clones were false-positives and could 
not be confirmed by retransformation assays or did not show the correct open reading frame. 
The following interacting proteins were identified: a subunit of the DNA-repair Ku complex 
named Ku70, the transcription factor testis zinc finger protein (tZFP) and the inhibitor of 
activated STAT (iSTAT). The initial growth phenotype of the prey Ku70 was observed up to  
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15 mM 3AT. After retransformation, the growth phenotype of Ku70 did not change (Fig.1 
and Tab.1). In each case, the three clones were positive for signal β-galactosidase activity 
after retransformation (data not shown). The nucleotide sequence of Ku70 corresponds to the 
C-terminal end (nucleotides 891-2147) of Ku70 cDNA. The full length Ku70 has a predicted 
size of 70 kDa and protein domain searches revealed a protein-protein interaction site in the 
C-terminus of Ku70 (572-606 amino acids), termed SAP.  
The initial growth phenotype of the two often potential interactors – tZFP and iSTAT – 
showed an enhanced growth up to 50 mM 3AT. After retransformation both putative 
interactors conferred yeast growth up to 15 mM 3AT (Fig.1 and Tab.1) sequencing revealed 
the correct open reading frame, matching with tZFP or iSTAT cDNA in the GenBankTM 
database. The nucleotide sequence of identified tZFP corresponds to nucleotide 211-1674. 
Two zinc finger motifs are located in the C-terminus of tZFP protein and represent potential 
DNA-binding sites, suggesting that tZFP functions as a transcriptional activator. The full-
length of tZFP has a predicted molecular weight of 53 kDa.  
iSTAT (predicted size of 63 kDa) contains the protein-protein interacting motif SAP as also 
known from Ku70. The functional role of iSTAT is the involvement in the JAK-STAT signal 
transduction pathway, regulating cellular processes like proliferation, differentiation and 
apoptosis [16].  
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Figure 1: Interaction of the kinase domain of human PASKIN with Ku70 (274-609 aa), testis zinc finger protein 
tZFP (59-471 aa) and full-length inhibitor of activated STAT. After retransformation in yeast, positive clones 
were plated on triple nutrient selection (medium lacking tryptophan, leucine and histidine) and different 3AT 
concentrations, in comparison with positive (POS) and negative (NEG) control plasmids. POS: pAct2-LargeT 
and pLexA-p53, NEG: pAct2-LargeT and pLexA-LaminC. No interaction with any of the three putative 
interactors of PASKIN was observed with the empty bait vector pLexA. 
 
 
Table 1: Three potential proteins interact with the kinase domain of PASKIN in the yeast two-hybrid screen. 
After retransformation and sequence analysis, the Ku70 protein, a testis zinc finger protein and the inhibitor of 
activated STAT were identified as PASKIN interactors.  
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In vitro interaction 
 
To determine whether Ku70, tZFP and iSTAT interacted directly with the kinase domain of 
PASKIN in vitro, proteins were bacterially expressed and purified as fusions to GST tag. The 
purified proteins were immobilized to glutathione-sepharose beads and incubated with the in 
vitro translated [35S]-labeled kinase domain of PASKIN. After analyzing by 
phosphorimaging, the C-terminal part of Ku70 strongly interacts with the kinase domain of 
PASKIN and a weaker interaction was observed for the full-length Ku70 (Fig.2). The testis 
zinc finger protein and the iSTAT did not interact with PASKN in vitro. The eukaryotic 
translation elongation factor eEF1A1 served as positive control and the GST tag alone was 
used as negative control. In conclusion, we have shown that Ku70 is the only novel PASKIN 
interactor that could be confirmed by GST pull-down assays, showing an even stronger 
interaction with PASKIN in vitro than the positive control eEF1A1. 
 
 
 
Figure 2:  GST pull-down assay. IVTT (35S)-labeled kinase domain of PASKIN was incubated with equivalent 
amounts of recombinant protein (Rec. Protein) GST alone or (A) GST fused to full-length eEF1A1, Ku70 and C-
terminus of Ku70 and testis zinc finger protein (tZFP) (B) GST fused to full length inhibitor of activated STAT 
(iSTAT) and C-terminus Ku70. Input (5%) is indicated.  
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In vitro target phosphorylation  
 
We previously reported that eEF1A1 is phosphorylated by PASKIN at Thr 431 [14]. In order 
to analyze whether Ku70 is also phosphorylated by PASKIN, kinase assays were performed. 
Therefore, PASKIN was purified from baculovirus-infected Sf9 cells and bacterially 
expressed and purified proteins fused to GST were used as targets. The autophosphorylation 
of PASKIN is stimulated by various phospholipids such as phosphatidic acid (PA), 
phosphatidylserine (PS) and phosphatidylethanolamine (PE), but not diacylglycerol (used in 
form of dioctanoylglycerol, DOG) [17]. As shown in Fig. 3A the presence of phospholipids 
enhanced PASKIN autophosphorylation. However, Ku70 is not phosphorylated by PASKIN 
and the phospholipids PA, PS, PE or the second messenger molecule DOG did not stimulate 
PASKIN dependent Ku70 target phosphorylation. Compared to Ku70, the positive control 
eEF1A1 is phosphorylated by PASKIN. Interestingly, PA represses the phosphorylation of 
eEF1A1 by PASKIN. 
It has been shown that the protein kinase PKCδ phosphorylates the eukaryotic EF1A1 at the 
same site like PASKIN [14,18]. Surprisingly, we could show that Ku70 is also 
phosphorylated by PKCδ  and the target phosphorylation is enhanced in the presence of the 
classical PKC activators PS and DOG (Fig. 3B).  
 
 
 
Figure 3: Phosphorylation assays. (A) PASKIN autophosphorylation and target phosphorylation with or without 
the phospholipids: phosphatidic acid (PA), phosphatidylserine (PS), phosphatidylethanolamine (PE) and the 
second messenger molecule dioctanoylglycerol (DOG). The positive control eEF1A1 is phosphorylated by 
PASKIN and shows an inhibition of eEF1A1 phosphorylation in the presence of PA.  
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DISCUSSION 
 
Our lab previously generated PASKIN knock-out mice which show a normal development, 
growth and reproduction. Surprisingly, PASKIN was found to be highly upregulated in the 
postmeiotic stage of spermatogenesis [11]. Because the absence of PASKIN did not influence 
male fertility, production or motility of sperms, the question of the functional role of PASKIN 
during the spermatogenesis arose. To get more insights into the function of PASKIN, a yeast 
two-hybrid screen with the kinase domain of PASKIN as bait and a human testis cDNA 
library was performed. From three putative interactors in yeast only one interactor could be 
confirmed in vitro by a GST pull-down assay. Following optimization of the experimental 
conditions, the yeast two-hybrid screening was repeated several times, but the average of the 
transformation efficiency of 6-8×103 clones/μg library could not be further enhanced to reach 
the predicted transformation efficiency of 104 to 105 clones/μg. The total number of 7.9×104 
screened colonies reflects only a little part of the expected number of 3.5×106 independent 
clones (Clontech, manufacturer manual) of the human testis cDNA library.  
The outcome of this yeast two-hybrid screening was the identification of the DNA-repair 
protein Ku70 interaction with PASKIN, which could be confirmed by GST pull-down assay 
in vitro. In contrast to eEF1A1, Ku70 is not phosphorylated by PASKIN in vitro, whether or 
not phospholipids were present. Ku70 is a multifunctional protein mainly involved in DNA 
repair as well as in many other cellular processes, including V(D)J recombination, telomere 
maintenance, transcription and apoptosis [15]. Recently, Ku70 and Ku80 were identified as 
interaction partners of the pancreatic duodenal homeobox-1 protein (PDX-1) in pancreatic β-
cells [19]. The transcription factor PDX-1 is involved in glucose-stimulated insulin response 
and is phosphorylated in vitro by DNA-PK at threonine 11. Furthermore, Lebrun et al. 
demonstrated that radiation leads to a decrease of PDX-1 protein level and degradation of 
PDX-1 by proteasome. Decreased insulin promoter activity as well as the PDX-1-mediated 
target gene expression of glut2 and glucokinase was also observed. Interestingly, promoter 
activity studies with the PDX-1 and preproinsulin genes showed that PASKIN increases 
promoter activity of both genes after elevated glucose concentrations in vitro [20]. Increasing 
glucose levels allegedly stimulate PASKIN activity in pancreatic β-cells and result in an 
upregulation of PASKIN mRNA expression and protein level [20]. However, our lab reported 
contrary data: PASKIN mRNA expression was not influenced after enhanced glucose 
stimulation in pancreatic β-cells. No differences in blood glucose levels and glucose tolerance 
were observed between wild-type and Paskin knock-out mice. The fact that PASKIN is highly 
expressed in the testis suggests that glucose stimulated insulin production in pancreatic β-cells 
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is independent of PASKIN [11,21]. However, PASKIN phosphorylates PDX-1 at Thr152 in 
vitro which probably inhibits the translocation of PDX-1 within the nucleus [22]. The 
observation that PASKIN as well as PDX-1 interact with Ku70, propose that PASKIN might 
be involved in phosphorylation of PDX-1 in a Ku70 dependent manner, thereby decreasing 
insulin promoter activity. The contrary data, whether PASKIN decrease or increase insulin 
promoter activity, propose a model which resolve this contradiction. Based on our finding that 
phosphatidic acid stimulates PASKIN autophosphorylation, but inhibits eEF1A1 target 
phosphorylation, these data suggests that PDX-1 phosphorylation is inhibited by PASKIN 
after activation of formed phosphatidic acid under high glucose conditions. Therefore, PDX-1 
is translocated to the nucleoplasm, activating PDX-1-dependent gene expression [23-25]. It 
has been reported that other kinases such as PI 3-kinase are activated by elevated insulin 
concentration and stimulates nuclear uptake of PDX-1, resulting in further insulin secretion 
[26]. Low glucose level does not stimulate PASKIN autophosphorylation by phosphatidic 
acid. Hence, PASKIN might be able to phosphorylate PDX-1 at Thr152, resulting in 
inhibition of PDX-1 nuclear uptake and PDX-1-dependent gene expression. Therefore, Ku70 
is able to interact with PDX-1 and DNA-PKcs-mediated phosphorylation of PDX-1 leads to 
degradation of PDX-1 by proteasome. PASKIN phosphorylation of PDX-1 at Thr152 might 
influence PDX-1 proteasomal degradation by stress-inducer such as low glucose 
concentrations. However, it would be interesting to investigate, whether overexpression of 
PASKIN influence PDX-1 proteasomal degradation in mouse embryonic fibroblasts (MEF’s) 
derived from wildtype or Ku70 null mice after PA treatment or stress conditions such as low 
glucose concentrations.  
In conclusion, Ku70 interacts with the kinase domain of PASKIN in yeast and in vitro, and is 
not phosphorylated by PASKIN. The lack of Ku70 phosphorylation suggests that PASKIN 
might phosphorylate Ku70-associated proteins such as PDX-1 leading to decreased promoter 
activity of insulin.  
Additionally, we identified Ku70 as phosphorylation target of PKCδ in vitro which was 
unknown so far. 
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8. CONCLUSIONS 
 
PASKIN, a novel PAS AMP-kinase related serine/threonine kinase appears to be involved in 
a wide range of cellular processes. However, little is known about the functional role of 
PASKIN in the cell. To elucidate the function of PASKIN we searched for novel interaction 
partners of PASKIN to get more insights in the pathways PASKIN is involved. In a yeast 
two-hybrid screening, we identified the eukaryotic translation elongation factor eEF1A1. We 
could show that the C-terminus of eEF1A1 interacts with both the PAS A and the kinase 
domains of PASKIN in GST pull-down assay as well as in a mammalian two-hybrid system. 
Furthermore, we demonstrated PASKIN-dependent target phosphorylation of human eEF1A1 
at Thr432. It has been reported that the multifunctional eEF1A1 is also phosphorylated by 
other kinases such as PKCδ, Rho-associated kinase and S6 kinase [1-3]. Interestingly, PKCδ-
dependent phosphorylation site on eEF1A1 has been described for the corresponding mouse 
protein at Thr431 [1]. The physiological role of eEF1A1 phosphorylation by PASKIN is 
unknown so far, but suggests an involvement of PASKIN in translation elongation. Indeed, in 
a cell-free translation assay we could show that PASKIN increases protein translation. 
PASKIN knock-mice show normal development, growth and reproduction and revealed a 
high expression level of PASKIN in the testis during postmeiotic stage of the 
spermatogenesis. Surprisingly, PASKIN and eEF1A1 co-localized in the midpiece of human 
sperm tails using a newly generated monoclonal anti-PASKIN antibody. No corresponding 
cell culture model exists, hence we can only speculate that PASKIN might be involved in 
protein translation in human sperms. Apart from protein translation, it has been demonstrated 
that eEF1A1 seems to be involved in apoptosis [4-6]. Thus, we investigated whether PASKIN 
overexpression leads to apoptosis in testicular germ cell lines (NTERA, NCCIT, G-C1 and G-
C2). None of the stressors like elevated temperature, hydrogen peroxides, serum free- or 
glucose-free medium induced PASKIN-dependent apoptosis (unpublished data). It will be 
interesting to investigate, whether stress-induced apoptosis differs in mouse embryonic 
fibroblasts (MEFs) derived from wildtype or PASKIN null mice. We demonstrated that 
endogenous PASKIN is localized in the cytoplasm as well as in the nucleus of HeLa cells and 
found PASKIN expression also in HEK293 cells. Using shRNA to stably downregulate 
PASKIN expression in these cell lines will help to elucidate the putative role of PASKIN 
during apoptosis for example by caspase-apoptosis-assays.  
Because of the same eEF1A1 site is phosphorylated by PASKIN and PKCδ, we analyzed 
whether PASKIN might be activated by classical co-activators of PKCδ. Surprisingly, we  
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could show that phospholipids, but not the second messenger diacylglycerol, stimulate 
PASKIN autophosphorylation. Phosphatidic acid (PA), a charged phosphate moiety that is 
produced by PLD interacts with PASKIN in contrast to diacylglycerol generated by PLC. 
Interestingly, PA stimulates PASKIN autophosphorylation, but inhibits eEF1A1 target 
phosphorylation by PASKIN in vitro. These data have to be reproduced in vivo by a co-
immunoprecipitation of PASKIN and eEF1A1 to check the phosphorylation status of 
PASKIN autophosphorylation and eEF1A1 target phosphorylation by anti-phosphothreonine 
antibody. Recently, it has been reported that glucose-stimulated insulin release leads to an 
increase in cellular PLD activity in pancreatic MIN6 cells [7]. The involvement of PASKIN in 
the regulation of PDX-1 is fortified by Rutter and colleagues. They conclude from their data 
that activated PASKIN enhances PDX-1 expression and translocation to the nucleus, leading 
to an increase in preproinsulin expression in pancreatic β-cells [8]. On the other site PDX-1 is 
known as phosphorylation target of PASKIN and is phosphorylated at Thr152 in vitro, 
leading to inhibition of PDX-1 nuclear translocation [9]. Based on our findings, a model is 
shown in figure 1 which might resolve this contradiction. Elevated glucose concentration 
might stimulate an intracellular signalling pathway that activates PLD resulting in increased 
PA formation. PA triggers PASKIN autophosphorylation, but inhibits PASKIN PDX-1 
phosphorylation such as we observed for eEF1A1. It has been reported that PDX-1 is 
translocated by importin β [10] from nuclear periphery into the nucleoplasm [11,12] and 
activates transcription of genes such as preproinsulin [13], Glut2 [14] and glucokinase [15]. It 
has been reported that other kinases such as PI 3-kinase are activated by elevated insulin 
concentration and stimulates nuclear uptake of PDX-1, resulting in further insulin secretion 
[16]. Under stress conditions, such as low glucose, PASKIN might not be stimulated by PLD 
formed phosphatidic acid, leading to PDX-1 phosphorylation by PASKIN at Thr152. It has 
been reported that importin binds to the C-terminus of PDX-1 (146-206 aa), suggesting that 
PDX-1 phosphorylation at Thr152 inhibits the interaction of importin β and PDX-1 [10]. 
Thus, PASKIN phosphorylation inhibits the nuclear uptake of PDX-1 and insulin expression 
[9].  
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Figure 1: Hypothetical model for the involvement of PASKIN stimulation by phosphatidic acid in pancreatic β-
cells. (A) Under high glucose concentrations PA is formed by PLD and stimulates PASKIN 
autophosphorylation, resulting in an inhibition of PDX-1 target phosphorylation by PASKIN on Thr152. Thus, 
PDX-1 is translocated by importin β from the nuclear periphery into the nucleoplasm. The transcriptional 
activation of PDX-1 target genes takes place and results in insulin secretion. By elevated insulin concentrations, 
other kinases such as PI 3-kinase are known to activate nuclear uptake of PDX-1, resulting in insulin secretion. 
(B) Under stress conditions such as low glucose concentrations PASKIN is not stimulated by PA and 
phosphorylates PDX-1 at Thr152. PASKIN target phosphorylation inhibits PDX-1 to translocate into the 
nucleoplasm. Stress-induced activation of the Ku70-Ku80-DNA-PKcs-complex e.g. by radiation leads to the 
phosphorylation of PDX-1 at Thr11, resulting in a proteasomal degradation of PDX-1. Low glucose as well as 
radiation show a decrease in PDX-1 target gene expression and low level of insulin secretion.  
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We identified the DNA-repair protein Ku70 as PASKIN interactor in a further yeast two-
hybrid screening with a human testis cDNA library. This interaction could be confirmed in a 
GST pull-down assay. However, Ku70 was not phosphorylated by PASKIN in vitro. It has 
been reported that PDX-1 interacts with Ku70 and Ku80 in pancreatic β-cells and is 
phoshorylated at Thr11 in vitro by DNA-PKcs [17]. It has been shown that radiation leads to 
the proteasomal degradation of PDX-1 [17]. The observation that PASKIN as well as PDX-1 
interact with Ku70, suggests a PASKIN-dependent phosphorylation of Ku70 interacting 
proteins such as PDX-1. In our lab, we could not confirm a glucose-dependent increase in 
PASKIN mRNA levels [18]. Therefore, nutrients might induce PASKIN activity rather than 
PASKIN mRNA or protein levels. It will be interesting to investigate whether PASKIN 
autophosphorylation is stimulated in a PLD-dependent manner in pancreatic β-cells as well as 
PDX-1 phosphorylation is inhibited by PASKIN after PA-treatment. Apart from insulin 
induced PLD activation, phosphatidic acid generated by PLD seems to be also involved in F-
actin formation in sperm capacitation and acrosome reaction [19]. Immunofluorescence with 
an anti-PA antibody might reveal the same localization of PA in the midpiece of sperm cells 
such as we could demonstrate for PASKIN. In yeast is known that eEF1A1 influences actin 
interactions and bundling [20]. Therefore, we performed an actin bundling assay, but we 
could not show that PASKIN interacts with F-actin in this assay, suggesting that PASKIN 
does not regulate actin cytoskeleton organization (data not shown). It will also be interesting 
to repeat this F-actin bundling assay with PASKIN stimulated by phosphatidic acid.  
By peptide and protein array screening, we identified further novel phosphorylation targets of 
PASKIN which are mainly involved in spermatogenesis, glycolysis and glycogen metabolism 
(data not shown). Among others, we could confirm the phosphorylation of mammalian 
glycogen synthase [21]. To confirm the phosphochip data and to reduce false positive 
substrates, we are planning an in vitro kinase phosphorylation assay on potential PASKIN 
target peptides.  
In conclusion, we identified the eukaryotic translation elongation factor eEF1A1 as 
interaction partner and phosphorylation target of PASKIN. We could show that the PASKIN 
autophosphorylation inducer phosphatidic acid inhibts eEF1A1 target phosphorylation. The 
identification of phospholipids as endogenous ligands for PASKIN stimulation is the first hint 
on the upstream regulators of PASKIN activity. Finally, we need more insights into 
phospholipid stimulated PASKIN activation and the resulting target phosphorylation in 
pancreatic β-cells as well as in the testis to understand the functional role of PASKIN in 
mammals.  
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